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The overall theme of this thesis is overuse and regional variation in use of health care 
services. Overuse and unwarranted variation are of global concern. Unnecessary health care 
services are recognized as harmful both to patients and health care systems. We have 
examined three different clinical scenarios where guidelines are either lacking evidence or 
where current practice is not in coherence with evidence-based recommendations. 
The aims of the thesis were: 1) to examine if deferred computed tomography (CT) for 
patients with a self-limiting episode of suspected urolithiasis lead to surgical treatment, 2) to 
quantify the extent and regional variation of routine pelvic examinations within publicly 
funded specialized health care in Norway, and assess if the use of colposcopy and ultrasound 
differs with gynecologists’ payment models, and 3) to assess if there are regional differences 
in rates of hospitalization and outpatient appointments for diverticular disease in Norway. 
In paper 1 we did a retrospective case series with data from the electronic health 
records at the University Hospital of Northern Norway. We identified the proportion of 
asymptomatic patients that were treated as a consequence of a positive finding on CT. Paper 2 
and 3 were both national cross-sectional studies with data from the Norwegian Patient 
Registry and Statistics Norway. In paper 2 we quantified the number of appointments for 
routine pelvic examination per 1000 women in Norway and for the 21 different hospital 
referral regions. We examined the use of colposcopy and ultrasound in these appointments for 
both fixed salary and fee-for-service gynecologists. In paper 3 we calculated the regional rates 
of hospitalizations and outpatient appointments for diverticular disease.  
Deferred CT for patients with self-limiting episodes of suspected urolithiasis led to 
surgical intervention in 1.8% of asymptomatic patients. Annually 22 per 1000 women in 
Norway had a routine pelvic examination with variation across regions from 7 to 44 per 1000. 
Gynecologist with fixed salaries used colposcopy in 1.6% and ultrasound in 75% of routine 
pelvic examinations. Fee-for-service gynecologists used the same procedures in 49% and 96% 
of appointments. Hospitalization rates for diverticular disease ranged from 95 to 179 per 
100 000 across regions. Outpatient appointment rates ranged from 258 to 655 per 100 000.   
Our results indicate that the practice of deferred CT for suspected urolithiasis is a low-
value health care service. Pelvic examinations are widespread with substantial regional 
variation. Fee-for-service reimbursements seem to skyrocket the use of colposcopy and 
increase the use of ultrasound in screening examinations. We found regional variation in both 




“Be sure to consult your physician before starting a new exercise program”  
Safety sign on tread mills in SATS Elixia Langnes, Tromsø 
 
The questions I address in this thesis all raised when I was serving as a junior doctor and 
observed what to me seemed like unexplainable differences in provided care among the 
different senior doctors I encountered. I was also intrigued by how various aspects of human 
life increasingly appeared to be considered as medical problems. Whenever I go to the local 
gym and read the safety signs on the tread mill, I get bewildered by the public faith in my 
profession. As a physician, I wonder what the content of such a consultation would be. What 
tests should I offer and what expectations might patients seeking me have? There are no 
specified screening tests to clear persons “fit for running.” Most likely, people themselves, 
without any professional help, are able to identify when tread mill running is a bad idea. 
The overall theme of this thesis is overuse and unwarranted regional variation of 
health care services. I have examined use of certain health care services in three distinct 
clinical scenarios; urolithiasis, routine pelvic examinations in asymptomatic women, and 
colonic diverticular disease. The three papers in this thesis examine frequently used health 
care services where guidelines are either lacking evidence or where current practice is not in 








2.1 Too much medicine 
“Much of clinical medicine remains empirical, and everyday practice is characterized by wide 
variations that have no basis in clinical science”  
Dr. John E. Wennberg1  
In 2002 BMJ published their theme issue “Too Much Medicine?”. Thirteen years later, the 
journal launched the Too Much Medicine campaign, this time without the question mark.2 
The 2010 editorial “How Less Health Care Can Result in Better Health”3 was the start of 
JAMA’s Less is More series,4 “documenting the ways that overuse of medical care fails to 
improve outcomes, harms patients, and wastes resources.” The Lancet published their Right 
Care Series in 2017.5  
The different terms used to describe the phenomenon of unnecessary health care 
services are overlapping and poorly defined.6-8 The term overdiagnosis is widely used, 
however, its definition is not settled and the concept is perceived differently by different 
people. In this thesis I will use the word overdiagnosis as a collective term for overdetection 
and overdefinition as defined by Brodersen et al.7 Overdetection is the mechanism of 
detection and diagnosis of asymptomatic abnormalities that never will progress to 
symptomatic disease. Overdefinition includes expanding disease definition to include very 
mild cases and lowering thresholds for defined risk factors without evidence on beneficial 
outcomes for the patients concerned. I will use the broader term overuse as defined by 
Chassin and Galvin for health care services where the “potential for harm exceeds the 
possible benefit.”9 Overuse include the subcategories overinvestigation and overtreatment. 
Overinvestigation and overtreatment deals with diagnostic and therapeutic procedures that do 
not alter patient outcomes to the better. I will also describe medical services that do not 
benefit the patient as unnecessary health care services. Low-value health care describe 
services that provide very little health benefit given the resources used.8,10 To me, the concept 
of “too much medicine” is not merely a strict medical assessment of harmful overdiagnosis 
and overuse, but also an ethical and philosophical notion that deals with medicalization of 
life, as described by Illich.11   
2.2 Extent of overuse 
The Too Much Medicine, Less is More and Right Care campaigns reflect the international 
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attention to the accumulating evidence of unnecessary health care utilization and 
overtreatment.10 Conferences,12,13 research institutes,14,15 professional organizations,16,17, 
popular science books,18,19 and medical campaigns20 address the harms of overuse and low-
value health care. Overuse is common in both high and low income countries.10 The 
Organisation for Economic Co-operation and Development (OECD) reckons that 20% of 
medical spending within OECD could have been spent more effectively, this number includes 
both overuse and ineffective economic management. OECD identify 20% of emergency 
department visits as inappropriate, 50% of antibiotic consumption as overuse with 
percentages as high as 90% in general practice, and 15% of all births as inappropriate 
cesarean sections without medical indications.21  
2.3 Measurement of overuse 
Overuse is understudied with limited practices directly reviewed.10,22 Methodologically, it is 
challenging to measure and document unnecessary health care services. Alongside a vaguely 
defined terminology the concepts of “benefit,” “harm,” and “value” are hard to operationalize. 
When do harms exceed benefits? How to measure whether outcomes could be the same, 
worse or better if “we did not do what we did?”  
2.3.1 Direct measures of overuse 
For established practices with well-documented appropriateness criteria, we can directly 
measure whether or not the right care is provided. All though there are limitations in regard to 
appropriateness applied to the individual patient using register data, and limitations in regard 
to external validity using patient case files, direct measurement is methodologically the most 
robust way to document overuse.10,23 However, only a minority of practices have well-defined 
appropriateness criteria.10 Consequently, only a subset of practices can be studied directly. 
For the many practices where well-established criteria are missing, or where limitations in 
data render direct measurement difficult, indirect approaches are used to identify overuse.  
2.3.2 Regional variation as an indirect measure of overuse  
“And what should they know of England who only England know?”  
Rudyard Kipling24 
Studies of regional variation in health care providing is an indirect, much used method to 
investigate potential overuse.25,26 Already in 1938 Glover documented regional variation in 
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tonsillectomy rates that could not be explained by illness.27 In 1973 Wennberg and Gittelsohn 
published their first study on small area variation.28 What was planned as a project to reveal 
potential insufficient medical providing in Vermont, gave evidence on high utilization and 
variation that was not explained by medical needs. Neighboring communities, with no 
acknowledged differences in morbidity, showed striking differences in use of numerous 
health care services.    
In studies of regional variation in health care utilization, three categories of health 
services emerge; effective care, preference-sensitive care, and supply-sensitive care.26 
Immunization of children and insulin to diabetes type 1 patients are examples of effective 
care. The proven benefits of effective care far outweigh the associated risks and harms. 
Preference-sensitive care is health care services where more than one intervention is 
medically acceptable. Examples are the choice between watchful waiting and prostatectomy 
after a diagnosis of early stage prostate cancer and whether or not a gallstone patient chooses 
to have an elective cholecystectomy. The last category, supply-sensitive care, deals with the 
frequency and threshold for using different services. How often should a patient on 
hypertensive drugs be controlled? When should a specialist be consulted? What are the 
indications for an elective tonsillectomy? These questions and countless others are left 
unanswered. Observed regional variation in these services is commonly caused by variation in 
supply, organization, and professional opinion rather than morbidity.26 The more specialists 
offering their services, the more patients will see a specialist. The more hospital beds 
provided, the more patients will be hospitalized. The more radiologists and imaging machines 
in an area, the more likely the inhabitants of that area will have an imaging exam.  
Documentation of regional variation in health care providing cannot directly be taken 
for evidence of either overuse or underuse. However, when regional variation cannot be 
explained by regional differences in morbidity or patient preferences, the variation is 
characterized as unwarranted.1 Indirectly, regional variation of effective care can indicate 
underuse in low-use area, while variation in preference- and supply-sensitive care might point 
to unnecessary health care services in high rates regions. Reports from the Dartmouth Institute 
and the Institute of Medicine have demonstrated extensive regional variation in use of supply-
sensitive care and medical spending with no associated improvement in outcomes or quality 
of care for patients in high use areas.29-31 Critics of variation studies raise concerns of 
inadequate adjustments for differences in morbidity and regional price differences.32 Even if 
interpretations are debated, regional variation in health service utilization is demonstrated 
internationally and is recognized as medically unwarranted.33 
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2.4 Drivers of overuse 
Overuse may seem counter-intuitive at first glance. As health care aims to help, it is difficult 
to perceive that less can be more, and to many it may seem incomprehensible that too much 
medicine can tip the balance towards harm. In the next section I will elaborate upon different 
contributing factors to unnecessary health care services before the backgrounds specific for 
the individual papers are provided.  
2.4.1 Lack of evidence 
There is a common belief among doctors, patients, policy makers, and the general public alike 
that medical practice is based on scientific evidence. However, shortage of evidence is rather 
the rule than the exception in everyday medical care. In less than 5% of Cochrane reviews the 
authors find sufficient evidence and no need for further studies on the conclusions drawn.34 
Where knowledge on a condition is insufficient, medical providers make clinical choices 
supported by best evidence available, logical thinking, and experience. Based on deductive 
reasoning and a strong belief in beneficial outcomes, physicians performed bloodletting as a 
remedy of innumerable maladies for millennia.35 Modern examples of treatments 
recommended by expert opinion include radical mastectomy for all cases of breast cancer, 
class 1c antiarrhythmics for stroke prevention, advising parents to make their babies sleep 
face down, synthetic estrogen to prevent stillbirth, and pulmonary artery catheters for heart 
failure patients.36 When set to test, none of these interventions have proven beneficial, on the 
contrary; they have all caused considerably harm including numerous unnecessary deaths. 
While the listed practices are now abolished, there are still countless other tests and 
treatments that are recommended purely by expert opinion.  
For recommendations truly based on scientific studies, many do not measure up when 
retested. In a 2018 study Silberzahn et al. demonstrated how statistical analyses applied to 
data material can highly influence study results.37 The researchers provided the same data set 
to 29 different analytical teams. Whereas two thirds of teams found a significant positive 
effect for the study outcome, one third found no relationship. In New England Journal of 
Medicine, 40% of articles testing standard of care conclude with medical reversal; the 
established medical practice is contradicted by new and superior evidence.38 Also highly cited 
original research articles claiming effective interventions are commonly reversed. In 2005 
Ioannidis showed that 16% of such articles with more than 1000 citations published in New 
England Journal of Medicine, JAMA, and Lancet were contradicted in subsequent studies.39  
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Publication bias adds additional burden to the shortcomings of evidence in today’s 
medical practice. Approximately 50% of all clinical trials are never reported, and positive 
findings are  more likely to be published compared to studies with negative results.40 In a 
review of 74 industry-sponsored studies of 12 different antidepressants, 37 of the 38 studies 
with positive results were published. As a contrast, only 3 of the 22 studies perceived by the 
Food and Drug Administration to have negative results were published accordingly, and 5 
studies were published as being positive. While the analysis by the Food and Drug 
Administration showed that 51% of all trials were positive, only analyzing the published 
trials, 94% were positive.41  
2.4.2 Shortcomings of medical guidelines 
In order to avoid the dangers of unscientific medical care, evidence-based medicine emerged 
as a paradigm shift in the early 1990s.42 Evidence-based guidelines have an increasing role in 
everyday clinical practice and are internationally recognized as a tool to enable quality and 
improve patients outcomes.43,44 Guidelines aim to improve the quality of medical care by 
providing a balanced, unbiased, and easy accessible summary of current medical evidence.45 
Unfortunately, lack of evidence, methodological standards, and implementation cause for 
concern.44 Lower level evidence and expert opinion commonly account for the majority of 
recommendations presented.46-49 A shortcoming of numerous guidelines is the absence of 
primary care perspectives.50 Half of recommendations for primary care are based on expert 
consensus, usual care, or disease-oriented evidence, while only 18% are based on high 
quality, patient-oriented evidence.51 Also, as reported by Pétursson et al. and Vinther et al., 
the sometimes monumental work load imposed on primary care by implementation of 
guideline recommendations is failed to be considered.52,53  
By starting with a specific condition, guidelines often provide the gold standard for 
establishing the correct diagnosis. However, basic questions are neither answered nor 
critically examined: When will a correct and proven diagnosis benefit the patient? When is it 
safe to wait and see? For how long time and to what degree should symptoms be present 
before advanced diagnostic testing is initiated?54,55 
Medical guidelines have the position to define both normal and disease, hence special 
caution to disease definition is warranted. When guidelines are updated, the definition of 
disease is commonly expanded without thorough balancing of benefits and harms of the 
proposed changes.56 The expanded definitions can lead to overdiagnosis through 
overdefinition. According to the updated blood pressure guideline from the American College 
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of Cardiology and the American Heart Association, where the cut off for hypertension is 
lowered from 140/90 to 130/80 mm Hg, the majority of adult Americans and Chinese are now 
defined as in need of intervention.57  
2.4.3 Early diagnosis  
A strong belief in the benefits of early detection and treatment has prevailed in medical 
societies for a century.58,59 In 1923 Dr. Bloodgood published an article on breast cancer 
research at Johns Hopkins Hospital: “If the lump felt by the patient proves to be cancer, its 
duration is the only controllable factor in the ultimate cure. If the lump felt by the patient is 
not cancer, it remains curable no matter how long its duration, and becomes dangerous only 
when it changes into cancer. Its removal, therefore, is protection from cancer.”58  
Dr. Bloodgood did not take into consideration that many lumps never progress to 
cancer. And many cancerous lumps will never progress to symptomatic disease. In a 
systematic review on autopsy studies 59% of all men >79 years old had prostate cancer.60 
Only 4.8% of men who died in Norway in 2017 died of prostate cancer.61 For thyroid cancer 
an autopsy study from Finland found occult papillary carcinoma in 36% of cases.62 The 
section interval was 2 to 3 mm. As many of the tumors found were small, the authors 
calculated on reducing the section interval, and concluded that by examining thorough enough 
almost every thyroid gland, if not all, would be identified as cancerous.  
Unfortunately, diagnoses of cancers that will never cause symptoms or death left 
untreated, overdiagnosed and overdetected cancers, are not only limited to corpses. As 
opposed to standard of care in 1923, today many women are diagnosed with breast cancer not 
after feeling a lump, but after screening participation. Exact estimates on rates of 
overdiagnosis within screening programs are vigorously debated. In 2012, Kalager et al. 
reported 15 to 25% of breast cancer cases diagnosed within the Norwegian Breast Cancer 
Screening Program to be overdiagnosed.63 The study was criticized for overestimating the rate 
of overdiagnosis by researchers from the Cancer Registry of Norway. The Research Council 
of Norway report 7% of invasive cancers diagnosed within the Norwegian Breast Cancer 
Screening Program as likely overdiagnosed, increasing to 15 to 17% when ductal carcinoma 
in situ diagnoses are included.64 These numbers are contrasted by substantially higher 
estimates reported by others. Jørgensen and Gøtzsche estimate the rate of overdiagnosis to be 
37%, increasing to 52% if ductal carcinoma in situ is included.65 Zahl and Mæhlen report that 
50% of cancer diagnoses within the Norwegian Breast Cancer Screening Program represent 
overdiagnosis, increasing to two thirds if ductal carcinoma in situ is included.66  
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The Nordic Cochrane Centre have reported that 50% of men screened for and 
diagnosed with prostate cancer are likely overdiagnosed.67 More than half a million people in 
12 high income countries are estimated to be overdiagnosed with thyroid cancer following 
screening.68 Despite controversy on exact estimates, overdetection is anticipated in screening. 
Contrary to Dr. Bloodgood’s believe, removal of lumps is not necessary protection from 
cancer. A healthy person cannot gain any extra health benefit by treatment of a case of 
overdiagnosed cancer.   
Acknowledging some of the shortages and harms of screening, the World Health 
Organization already in 1968 introduced criteria for screening tests.69 The Norwegian 
Directorate of Health recommends to use the same criteria with some amendments for 
screening programs in Norway. In a 16-point list considerations on test validity, treatment 
benefit, and evidence among others are emphasized. It is explicitly listed that the health 
benefits should be greater than the negative effects and that information on participation 
should be evidence-based and contribute to informed choice.70 The Norwegian Ministry of 
Health and Care Services has adopted many of the criteria in its national cancer strategy for 
2018-22.71 Foremost, national cancer screening programs should reduce disease specific 
morbidity and mortality. Test validity need to be high and the risk of adverse events low. 
Both the Norwegian Directorate of Health and the Norwegian Ministry of Health and Care 
Services stress the importance of defined, monitored screening programs, and that 
opportunistic screening should be reduced.70,71  
2.4.4 Diagnostic intensity of imaging diagnostics  
Imaging diagnostics plays a crucial role in every day clinical care and contributes to earlier 
diagnosis without invasive procedures. Concurrent with improved accuracy, the use of 
advanced imaging exams has increased tremendously the last decades. From 1996-2010 the 
use of magnetic resonance imaging and computed tomography (CT) increased by close to 
10% annually.72 Use of CT diagnostics for emergency departments patients in the US has 
increased by 330% from 1996-2007.73 There are several risks and harms embedded with 
imaging diagnostics; among others false positive exams, overdiagnosis, radiation exposure, 
and incidentalomas.74 Incidentalomas are asymptomatic findings, either benign or pathologic, 
that are shown on imaging exams ordered for an unrelated condition. In a study of whole-
body imaging screening, 86% of the 1192 participants had at least one abnormal finding. On 
average the participants had 2.8 findings each and 37% of participants were recommended 
further follow-up.75 Despite the high positive rates, whole-body imaging screening is 
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recommended against due to lack of evidence on improved patients outcomes in addition to 
high risk of false positive results.76 If current use of imaging examinations continues, an 
estimated 2% of all future cancer cases will develop as a result of radiation exposure.72  
2.4.5 Economic incentives  
Medical care accounts for more than 12% of the gross domestic product in OECD countries 
and the expenses are increasing.77 Economically, health care systems stand out. While other 
markets are regulated by demand and consumers’ willingness to pay, the public health care 
system itself to a large degree defines the need of the population. Trust is embedded in the 
patient-doctor relationship. Patients are not expected to possess the medical knowledge 
necessary to question the validity of recommendations provided by health care professionals. 
In addition, health care is in many countries, including Norway, to a large degree financed not 
by the patient, but by public reimbursements according to quantity of care. Contrary to other 
economic systems, the patients have no economic interest in refusing a diagnostic test or 
treatment offer. General practitioners and private specialists with public reimbursement in 
Norway are better paid if they perform numerous procedures. Likewise, also hospitals have 
fee-for-service reimbursements for selected procedures and care. Hence, there is an economic 
incentive to perform more, independently of medical need.  
Economic interests also affect medical care through control of medical evidence 
available with substantial influence on study questions, design, analysis, and reporting.78,79 
Economically biased publications have a substantial impact on clinical care.79 
2.4.6 Defensive medicine 
Defensive medicine is defined as the ordering of tests, treatments, and consultations in order 
to protect the health professional from malpractice litigation rather than improving patient 
outcomes.80 In an American survey study on overtreatment, physicians reported 21% of 
overall medical care as unnecessary with fear of malpractice as the most common cause 
(85%).81 In Norway malpractice litigation is seldom82 and the impact of fear of lawsuits is 
understudied.  
Compared to American conditions, malpractice litigation nevertheless seem to be less 
of a worry for Norwegian physicians. 14% of obstetricians report that perceived threats of 
lawsuit would influence their willingness to offer cesarean sections.83 Even if litigation is 
rare, Norwegian physicians have to deal with increasing expectations from the general 
public.84 General practitioners report that “to avoid overlooking anything” is a contributing 
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factor to 28% of referrals to specialized health care.85 Fear of complaints and pressure from 
patients and next of kin are frequent causes of overtreatment according to Norwegian 
physicians.86   
2.5 Norwegian public health 
All citizens of Norway have a legal right to equal access to good quality health care.87 
Specialized health care is organized into four Regional Health Authorities which in turn run 
altogether 21 different health enterprises. The Norwegian municipalities are allocated into 
different hospital referral regions, each region is served by a defined health enterprise. The 
health enterprises run one or several public hospitals and collaborate with a varying number 
of private providers. All citizens are entitled to a regular general practitioner. General 
practitioners function as gate keepers who, at need, refer patients to specialized health care. 
With few exceptions, all appointments within specialized health care warrant referrals. The 
morbidity is relatively homogeneous across regions.88 Nevertheless, there is considerable 
variation in health care provided for inhabitants of different regions.89 
The Regional Health Authorities are financed by block grants in addition to activity-
based funding. In 2012-13 block grants accounted for 60% and activity-based funding for 
40% of total funding. From 2014 the split has been 50/50.90,91 At public hospitals physicians 
are paid a fixed salary independent of quantity of care. Both private physicians and private 
hospitals that collaborate with the health enterprises are paid through a fee-for-service 
scheme; they receive reimbursements based on quantity of procedures and patient contacts.  
2.6 Background for the individual papers 
2.6.1 CT for suspected urolithiasis (paper 1) 
Urolithiasis is the formation of urinary stones, which are stones located anywhere in the 
urinary system including kidneys, ureters, and bladder. A calculus that passes from the kidney 
may cause urinary obstruction and renal colic. Acute episodes of urolithiasis are characterized 
by renal colic and hematuria.92 Pain relief is the number one priority for patients suffering an 
acute stone episode.55 Most stones pass spontaneously and thus do not require surgical 
intervention.93,94 Urolithiasis is common, affecting 5 to 10% of Europeans and North 
Americans.95,96  
Urolithiasis guidelines by the European Association of Urology and the American 
Urological Association recommend that patients presenting with suspected urolithiasis should 
be radiologically examined.55,97 This recommendation is not evidence-based. The guidelines 
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do not provide any advice on specific symptoms or clinical findings that should warrant 
imaging diagnostics, or when to rule out the necessity of such an examination.  
In Norway, patients with self-limiting episodes of suspected urolithiasis are 
recommended referral to CT of kidneys, ureters, and bladder (CT KUB) after 4 weeks to 
control stone passage.98 Again, this recommendation is not evidence-based. The radiation 
exposure, risk for incidentalomas, and costs associated with CT cause for concern.74,99  
2.6.2 Routine pelvic examinations (paper 2) 
Routine pelvic examinations are physical examinations of women’s pelvic organs used for 
screening purposes. Apart from cervical cancer screening at set time intervals, routine pelvic 
examinations lack evidence on positive outcomes and the practice is strongly recommended 
against in asymptomatic women.100-102 Neither screening colposcopy nor screening ultrasound 
is warranted.103,104 Pelvic ultrasound in asymptomatic women is associated with high rates of 
false positive findings with a 33% increased risk of oophorectomy105 and extensive use of 
unnecessary surgery.105,106  
2.6.3 Diverticular disease (paper 3) 
Diverticular disease is an umbrella term for diverticulosis, diverticular bleeding, and 
diverticulitis. Diverticulosis is a condition with several outpouchings of the colon. 
Diverticulosis is prevalent in developed countries with 50% of people aged 60 years or older 
being affected.107,108 The majority of affected patients will remain asymptomatic throughout 
their lifetime, while a subset will experience diverticulitis or diverticular bleeding.107,109 
Diverticular disease is a frequent cause of both hospitalizations and outpatient appointments 
for gastrointestinal disease.110   
Standard treatment for acute uncomplicated diverticulitis has until recently been 
hospital admission with intravenous antibiotics and dietary restrictions.111 This treatment 
approach is not based on evidence of beneficial outcomes. Lack of evidence and 
inconsistency in recommendations between different diverticular disease guidelines is rather 




3. AIMS OF THE STUDY 
The aims of the study were: 
  
• To investigate if deferred routine CT KUB for patients with a self-limiting episode of 
suspected urolithiasis lead to surgical treatment.  
 
• To quantify the extent of routine pelvic examinations within publicly funded 
specialized health care in Norway.  
 
• To assess if the use of routine pelvic examinations differs across hospital referral 
regions 
 
• To assess if the use of colposcopy and ultrasound in routine pelvic examinations 
differs with gynecologists’ payment models. 
 
 
• To assess if there are regional differences in rates of hospitalization and outpatient 




4. MATERIALS AND METHODS 
4.1 CT for suspected urolithiasis (paper 1) 
4.1.1 Study population and data collection 
Data for paper 1 was extracted from electronic health records at the state-owned University 
Hospital of Northern Norway (UNN). UNN is the only provider of CT diagnostics in the 
hospital referral region, serving 200 000 inhabitants. Through the radiological information 
system used at UNN, we identified all patients examined with a deferred CT KUB between 
January 1st, 2010 and December 31st, 2013. Based on the referral information, we included 
patients who were examined on the suspicion of urolithiasis. We excluded patients who had a 
CT verified urinary stone within 1 year prior to the CT where the stone was not removed, 
patients under the age of 18 years, pregnant women, and patients with persistent symptoms 
for more than 3 weeks at the time of referral. We sent all eligible patients (n=410) a letter of 
information and a consent form. Among invited patients, 48% (n=197) accepted to 
participate. Due to exclusion criteria, final analysis yielded 189 CT KUBs.  
4.1.2 Variables  
Patients who by the time of CT KUB were described as asymptomatic in the electronic health 
record were defined as asymptomatic in our analyses. For many patients we had no symptom 
description after CT referral, as they did not have any contact with specialized health care 
apart from the CT scan itself. We classified these patients as asymptomatic in our analyses, 
under the assumption that they did not suffer symptoms in need of specialized health care 
services. Information in the referral letter was used to classify symptom duration and whether 
or not patients had previous urolithiasis or hematuria at the time of referral. We defined 
surgical interventions as any surgical procedure to alleviate or treat urolithiasis including 
ureteroscopic lithotripsy, extracorporeal shock wave lithotripsy, and ureteral stenting. We 
classified interventions in asymptomatic patients as interventions induced by the CT KUB.  
4.1.3 Statistical analysis 
The primary endpoint was the proportion of asymptomatic patients who within 1 year from 
the initial CT KUB had surgical intervention induced by a positive finding of urolithiasis on 
the CT scan. To analyze the probability of both surgical intervention and a confirmed 
diagnosis of urolithiasis on CT KUB, we performed logistic regression analyses with age, sex, 




4.2 Routine pelvic examinations (paper 2) 
4.2.1 Study population and data collection 
Data for paper 2 were extracted from the Norwegian Patient Registry (NPR) in addition to 
demographic statistics from Statistics Norway. All public hospitals and private providers of 
publicly funded specialized health care in Norway are obliged to report diagnoses, 
procedures, and patient’s residency of every patient discharge and outpatient appointment to 
NPR. The reports are linked to the patients through the unique personal identification number 
of all inhabitants of Norway. Diagnoses are reported to NPR according to the annual 
Norwegian version of the International Classification of Diseases version 10 (ICD-10).113 
Surgical, radiological, and medical procedures are reported according to the NOMESCO 
Classification of Surgical Procedures (NCSP), the Norwegian Classification of Radiological 
Procedures, and the Norwegian Classification of Medical Procedures.114 Fee-for-service 
physicians also include tariff codes from “Tariff for publicly funded private physicians”115 in 
their reports.  
We included all Norwegian women aged 18 years and older in Norway in the years 
2014-16 (n=2 016 852).  
4.2.2 Variables  
Routine pelvic examinations were defined as a primary diagnosis of ICD-10 Z01.4; 
“Encounter for gynecological examination without complaint, suspected or reported 
diagnosis.” We defined colposcopy by the allocation of any of the procedural codes for 
colposcopy in the 2014-16 versions of NCSP (XLE 00, LXE 00) or “Tariff for publicly 
funded private physicians” (208). Likewise, we defined ultrasound by the allocation of any of 
the procedural codes for transvaginal ultrasound in the 2014-16 versions of the Norwegian 
Classification of Radiological Procedures and the Norwegian Classification of Medical 
Procedures (LXDE05, SLXOBK, SLXOAK) or “Tariff for publicly funded private 
physicians” (211c). Fee-for-service physicians can claim reimbursement for “complete 
examination performed by a specialist (after referral)” through the tariff code 4b1. We defined 
“complete examination” by the allocation of code 4b1. 
The term “fixed salary gynecologist” refers to gynecologists working in public 




4.2.3 Statistical analysis 
We quantified the number of appointments for routine pelvic examination per 1000 women in 
Norway and for the 21 different hospital referral regions, standardized for age. We examined 
the use of colposcopy and ultrasound in these appointments for both fixed salary and fee-for 
service gynecologists. Pearson’s chi-square test was used to compare differences between 
provider types. The impact registered secondary diagnoses had on regional variation and use 
of colposcopy and ultrasound, was examined. The use of “complete examination” at 
appointments at fee-for-service gynecologists, was also quantified. All numbers reported are 
the mean for 2014–16, unless otherwise stated. All regional rates were standardized by age 
with Jan 1st, 2016 as the standard population. We used SAS Enterprise Guide 7.1 for 
statistical analyses.116 
4.3 Diverticular disease (paper 3) 
4.3.1 Study population and data collection 
Data for paper 3 were extracted as described for paper 2. In this paper, we included all 
Norwegian citizens aged 40 years and older in Norway in the years 2012-16 (n=2 517 938).  
4.3.2 Variables 
We defined colonic diverticular disease as a primary diagnosis of any of the ICD-10 codes 
K57.2–57.9: “Diverticular disease of large intestine” and “Diverticular disease of intestine, 
part unspecified.” Discharges with codes for colitis or colon or rectal cancer, ICD-10 codes 
K50-52 and C18-C21, were excluded.  
Hospitalizations and outpatient appointments were defined by length of stay.  
Discharges with length of stay ≥ 1 day were defined as hospitalizations while appointments 
with length of stay of stay = 0 day were defined as outpatient appointments. Both 
hospitalizations and outpatient appointments were separated into acute or elective care 
according to allocated codes.   
Lower gastrointestinal (LGI) endoscopy was defined by the allocation of any 
procedural code for colonoscopy or sigmoidoscopy in the 2012-16 versions of NCSP 
(UJF 32, JUF 32, UJF 35, JUF 35, UJF 42, JUF 42, UJF 45, JUF 45, JFA 15) or in “Tariff for 
publicly funded private physicians” (115a, 114a).115 We defined “LGI endoscopy for any 
indication” as any use of LGI endoscopy, independent of allocated ICD-10 codes. 
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We defined surgery by the allocation of a procedural code for colonic resection (JFB 
20-97), colostomy (JFF 20-31 and 96-7), colectomy (JFH 00-96), or peritoneal drainage and 
irrigation (JAK 00-04) in NCSP. Surgery was classified as acute or elective according to the 
degree of urgency allocated for the relevant admission.  
The term “private physicians” refers to both fee-for-service physicians and physicians 
working at private hospitals with public reimbursement. As for paper 2, we used SAS 
Enterprise Guide 7.1 for the statistical analyses.116 
4.3.3 Statistical analysis  
We calculated the national and regional age- and sex-standardized rates of hospitalizations 
and outpatient appointments for diverticular disease per 100 000 inhabitants. We examined 
the use of LGI endoscopy in both hospitalizations and outpatient appointments for 
diverticular disease. We obtained the age- and sex-standardized rates of surgery for 
diverticular disease by the four Regional Health Authorities. Length of stay was analyzed for 
hospitalizations. We used Spearman’s correlation coefficient to examine the correlation 
between outpatient appointments and hospitalizations. In additional analyses we quantified 
the use of LGI endoscopy for any indication. We used Spearman’s correlation coefficient to 
examine the correlation between regional rates for outpatient appointments for diverticular 
disease and LGI endoscopy for any indication performed in outpatient appointments. All 
reported numbers are the mean for 2012-16, unless otherwise stated. We standardized all 
regional rates by age and sex with Jan 1st, 2015 as the standard population.  
4.4 Ethics 
Study approval for paper 1 was obtained from the Regional committee for medical and health 
research ethics (Rec North, 2014/1904-13). All participants gave written informed consent.  
For paper 2 and 3 The Norwegian Data Inspectorate licensed the data registry at 




5. MAIN RESULTS 
5.1.1 CT for suspected urolithiasis (paper 1) 
At the time of CT examination, 90% (n=171) of patients were asymptomatic, of whom 23% 
(n=40) had a positive finding of urolithiasis on the CT scan. Of asymptomatic patients, three 
(1.8%) were treated surgically and two (1.2%) had hydronephrosis. 
The three asymptomatic patients who underwent treatment were all middle-aged men. 
Two patients of whom one had hydronephrosis were each diagnosed with a 7 mm ureteral 
stone. The patient with silent hydronephrosis had suffered symptoms for 7 days before he 
spontaneously turned asymptomatic. The final treated asymptomatic patient had a 10 mm 
stable kidney stone.  
Among the asymptomatic patients with a positive finding of urolithiasis on CT KUB, 
62.5% (n=25) had kidney stones, 27.5% (n=11) had ureteral stones, and 10% (n=4) had 
bladder stones. Median size for kidney, ureteral, and bladder stones were 3 mm (range 1-14), 
4 mm (range 3-7), and 4 mm (range 4-4), respectively.  
In logistic regression models men had an odds ratio of 2.50 (95% CI 1.12-5.58) for a 
positive finding of urolithiasis compared to women. None of the other covariates were 
significant for a confirmed diagnosis of urolithiasis. Surgical intervention could not be 
predicted by any of the covariates.   
In addition to urolithiasis, the CT scans also revealed numerous other findings. One 
asymptomatic patient received treatment for an incidental finding of a small intestine 
adenocarcinoma and three symptomatic patients were diagnosed and treated for other 
abdominal conditions. Physician visits and/or further imaging diagnostics was offered to 8.5% 
(n=16) of patients on the suspicion of a potential calculus or malignant process. All cases 
were concluded as insignificant findings with no need for further follow-up. 
5.1.2 Routine pelvic examinations (paper 2) 
Annually, there were 43 439 routine pelvic examinations in Norway, constituting 22.2 
examinations per 1000 women. Both the mean and the median age for women examined were 






The number of examinations ranged from 6.6 to 43.9 per 1000 women across the 
hospital referral regions. Fixed salary gynecologists performed one third (n=14 115) of pelvic 
examinations with the mean age of women examined being approximately the same as at fee-
for-service gynecologists (46.7 vs. 47.8 years, respectively).  
In comparison of payment models, gynecologists with fixed salaries performed 
colposcopy in 1.6% (n=249) of appointments with 49.2% (n=14 427) as corresponding 
number for fee-for-service gynecologists. Ultrasound was used in 74.5% (n=11 810) of 
appointments at fixed salary gynecologists while fee-for-service gynecologists used 
ultrasound in 96.2% (n=28 216) of appointments. Differences between provider types were 
statistically significant for both colposcopy (p < .001) and ultrasound (p < .001). Fee-for-
service gynecologists claimed reimbursement for “complete examination” in 87.3% of routine 
pelvic exams. 
Secondary diagnoses were registered in 16.5% of examinations. More than 850 
different secondary diagnoses were used, many with no relevance to the female genitalia. 
Both fixed salary and fee-for-service gynecologists used colposcopy and ultrasound slightly 
more frequently in appointments with secondary diagnoses than appointments without such 
diagnoses. Excluding appointments with secondary diagnoses caused minor sequence 
replacements of five regions in the analysis of regional variation and did not diminish the 
differences between provider types in use of colposcopy and ultrasound.   
5.1.3 Diverticular disease (paper 3) 
Hospitalization rates were stable during the study period with 132 hospitalizations per 
100 000 inhabitants. Across regions there was a 1.9-fold variation in hospitalization rates 
from 95 to 179 per 100 000 inhabitants. In all regions the median length of stay was either 
two or three days. Acute hospitalizations accounted for 84% of admissions.  
Surgery rates for diverticular disease were stable during the study period with 16 
surgery admissions per 100 000 inhabitants. Acute surgery was less common than elective 
and accounted for 32% of the overall amount. Across the Regional Health Authorities 
regions, there was a 1.3-fold variation in surgery rates, from 15 to 19 per 100 000 inhabitants.  
Over the study years, the mean rate of outpatient appointments for diverticular disease 
was 381 per 100 000 inhabitants, with a 37% increase in annual rates from 2012-16. Across 
regions there was a 2.5-fold variation in outpatient appointment rates from 258 to 655 per 
100 000 inhabitants. Outpatient appointments were mainly elective (92%). Outpatient 
appointments and hospitalizations across regions were strongly correlated (rs=0.69, p<0.001).  
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LGI endoscopy was frequently performed in outpatient appointments for diverticular 
disease and less commonly during hospitalizations, 76% vs. 15%, respectively. In outpatient 
appointments at public hospitals LGI endoscopy was used in 72% of appointments. Private 
physicians performed LGI endoscopy 1.3 times as often and used the procedure in 96% of 
appointments. During the study period there was a 39% increase in the annual rates of 
outpatient appointment with LGI endoscopy for diverticular disease. 
From 2012-16, the annual rates of LGI endoscopy for any indication increased by 6% 
in hospitalizations and by 35% in outpatient appointments. Regional outpatient LGI 
endoscopy for any indication and outpatient appointments for diverticular disease was 
strongly correlated (rs=0.72, p<0.001).   
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6. GENERAL DISCUSSION 
6.1 Methodological considerations 
The Too Much Medicine Movement and studies of overuse are criticized for oversimplifying 
the complexity of medical practice.32 Admittedly, the terms used are often hard to 
conceptualize and clearly value dependent. To directly measure overuse necessitates well-
accepted appropriateness criteria, which for most conditions are lacking. The updated 
American College of Cardiology/American Heart Association high blood pressure guideline 
and the following debate exemplify how hard it is to achieve consensus even for conditions 
with a massive evidence base.117-119 Assessing the same evidence, different guideline panels 
suggest a small reduction in the risk of cardiovascular events with lower blood pressure 
targets. However, panels differ in how they value the estimated risk reduction. While the 
American College of Cardiology and the American Heart Association emphasize the 
treatment benefit when they define hypertension as blood pressure ≥130/80 mm Hg,117 the 
Norwegian Directorate of Health, the American Academy of Family Physicians, The 
American College of Physicians, the European Society of Cardiology, and the European 
Society of Hypertension judge differently. Based on no reduction in either cardiovascular 
disease mortality or all-cause mortality, lack of systematic assessment of harms associated 
with blood pressure treatment, and risk of overdiagnosis and overtreatment, the latter 
guidelines keep blood pressure ≥140/90 mm Hg as hypertension cutoff. 119-121  
How to balance small benefits or benefits to very few patients versus harms of overuse 
and medicalization is not answered by medical trials. In Paper 1 we argue that the practice of 
deferred CT KUB following a self-limiting episode of suspected urolithiasis is low-value. The 
term is commonly used to describe services that provide very little health benefit given the 
resources used, with neither “low” nor “value” precisely defined.8,10 Some argue that low-
value health care only should describe services that have been assessed with a systematic 
cost-effectiveness analysis, as it would make the term more operational.8 This approach 
would emphasize the economic aspect when assessing the value of a health service, and 
rendering low-cost services with minimal health benefits excluded from the term. Moreover, 
also cost-effectiveness analyses are left with subjective assessments in balancing costs versus 
effectiveness and benefits. The perils of medicalization cannot be properly covered by cost-
effectiveness analysis. To appreciate the complexity of health and the impact of medical 
practice, we have in the papers included in this thesis accepted the vagueness of “value.” 
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There are many gray areas in medical practice where definite answers regarding right 
or wrong care is hard to achieve.10 It is challenging to assess whether a little too much is 
better than the risk of a little too little. Nevertheless, this acknowledgement should not limit 
the scope of medical research to questions that can be addressed only by more rigorous 
methods.   
Studies of regional variation are recognized as useful indirect tools for identifying 
overuse.1,25,26 A methodological concern is how to identify unwarranted variation within 
observed variation.122 Observed variation consists of both a random and a systematic 
component. Some degree of variation is expected due to chance and is hence warranted. Also, 
within the systematic component of observed variation, some variation is medically 
explainable due to differences in disease burden. Unwarranted variation is the part of 
systematic variation that cannot be explained by differences in morbidity or patient 
preferences.1  
The statistical analyses applied in variation analyses are understudied and their 
validity in identifying unwarranted variation is questioned.123 There is no acknowledged 
method to discriminate between random and systematic variation.124 The size of our studies is 
in this regard an advantage. The studied conditions are common, and the numbers are so high 
that the impact of random variation should be limited.  
Variation studies are criticized for incapacities in adjusting for severity of illness.122 
This is less of a concern in Norway, where there are few acknowledged differences in 
morbidity.88 To adjust for differences in demographic factors we standardized all analyses in 
paper 2 by age and in paper 3 by sex and age. Though theoretically a concern, studies so far 
have shown that patient preferences have little impact on regional variation.125  
6.2 Methodologic considerations related to the individual papers 
6.2.1 CT for suspected urolithiasis (paper 1) 
The practice of CT KUB for suspected urolithiasis is acknowledged as well-appropriate, and 
it is highly recommended. Hence, rather than measuring overuse, paper 1 is a study 
questioning established, though not evidence-based appropriateness criteria.  
Paper 1 is a case series. Due to the observational, descriptive, and retrospective 
design, we have not been able to directly compare outcomes between patients examined with 
deferred CT KUB and patients not examined. As deferred CT KUB is recommended practice, 
and presumably the majority of eligible patients get examined, comparison between groups in 
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regular clinical practice would be very limited. We could not carry out a medical trial to test 
for differences in outcomes due to lack of support from the Departments of Urology and 
Radiology at UNN.  
Specific concerns for our study was non-response bias due to low participation rate 
and bias as a result of missing information in the patient files. Low participation rates are 
expected in epidemiological studies, especially when postal recruitment is carried out years 
after the relevant episode. However, people who perceive the study question important on a 
personal level are more likely to participate than others.126 It seems unlikely that the non-
responders in our study would constitute a subgroup more severely afflicted with urolithiasis 
than those who participated. Hence, our low benefit conclusion is probably not threatened by 
differences between responders and non-responders. To increase participation rate, we could 
have pre-contacted invited patients, used incentives, or sent postal follow-up to non-
responders.127 However, these approaches were not approved by the ethical committee.  
Urolithiasis is referred to as kidney stone in Norwegian lay language, encompassing 
both kidney and ureteral stones. This term is used also by professionals.98 We could not 
differentiate between patients referred to CT KUB under the suspicion of ureteral or kidney 
stones, as most referrals asked for kidney stone diagnostics, while describing common 
ureteral stone symptoms. 
For the great majority of CT KUBs studied, the information in the medical record was 
limited to the referral letter and the radiological description of the CT scan. As symptom 
description in many case files were incomplete, there are uncertainties about symptom 
assessment for defined asymptomatic patients. The primary endpoint, the proportion of 
asymptomatic patients with CT KUB confirmed urolithiasis where the CT image led to 
surgical intervention, has consequently weaknesses. Patients we defined as asymptomatic 
might have suffered symptoms that were handled outside specialized health care. The medical 
record of one of the three treated asymptomatic patients did not provide information on 
symptoms after CT KUB referral. Hence, we were unfortunately not able to assess whether 
this patient was treated due to symptoms or the CT KUB report itself. As we did not want to 
minimize the benefits of CT diagnostics, we counted the patient as asymptomatic, even if we 
did not know the clinical presentation at the time of treatment.  
Some referral letters had missing or vague information on symptoms, hematuria, 
and/or previous urolithiasis. Hence, the regression analyses have several biases due to missing 
information and the results should be interpreted with caution. Especially information on 
previous urolithiasis and hematuria was limited, so unfortunately, our study cannot conclude 
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on the impact of these matters. Furthermore, even when precise information was given, we 
could not validate if the information was correct.  
The major strength of our study is that we have investigated a recommended and well-
established practice, a practice supported by expert opinion in the absence of studies on the 
topic. Even though some referral letters were insufficient in regard to patient history and 
clinical findings, our study still show the likelihood of surgical intervention after referral to 
deferred CT KUB. In real life, insufficient information in referral letters is a part of everyday 
clinical care. We believe our study, despite methodological shortcomings, gives important 
knowledge about outcomes of the routine practice of deferred CT KUB for suspected 
urolithiasis.  
6.2.2 Variation studies with data from the Norwegian Patient Registry (paper 2 and 
3) 
The two cross-sectional studies of this thesis share some strengths and limitations. By 
investigating differences in health care utilization rates across the different regions, we have 
found differences in provided care for the population independent of where the treatment was 
given. In this way, any intended collaboration between the providers will not affect the 
analyses. 
Imbedded in the registry study design are potential coding errors. We cannot validate 
the registered diagnoses. We have knowledge only of the discharge diagnoses, not the referral 
symptoms. Local code practice might vary. However, variation in code practice on the 
individual level is not likely to cause systematic variation over regions.  
Our studies are not able to demonstrate the causes of the observed regional variation. 
Regional variation might reflect regional differences in disease burden. Practice variation 
within a hospital referral region is often larger than between regions,128 hence reported 
regional utilization patterns might not represent any particular practice. Our studies examined 
only health care utilization in publicly funded specialized health care. Differences in primary 
care management may influence both outpatient appointment and hospitalization patterns. 
Also, we were not able to assess use and possible influence of privately out-of-pocket paid 
health care services with the data available.  
Secondary diagnoses are known to be underreported.129 Either reported or not-reported 
secondary conditions might have influenced the utilization patterns of health care services 
reported on in paper 2 and 3. Adjusting for comorbidities for routine pelvic examinations or 
diverticular disease is challenging, as there are no predefined lists of conditions of interest. 
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Moreover, by adjusting for comorbidities by other registered diagnoses, we would risk 
adjusting for differences in code practice and diagnostic intensity instead of real morbidity. 
Hence, we omitted adjusted analyses for paper 2 and 3. In paper 2 we did additional analyses 
were all appointments allocated a secondary diagnosis were excluded, to compare utilizations 
patterns between patients with and without registered secondary diagnoses. Registered 
secondary diagnoses had minimal impact on regional use. 
A major strength of the studies is that they include the entire sex- and age- defined 
population and contain every outpatient appointment and hospitalization for the given 
conditions in Norway during the study periods. The studied codes are the codes used for 
actual reimbursement payments to hospitals and fee-for-service physicians. Correct reporting 
is mandatory, economically important, and focused on in both settings. 
6.2.3 Routine pelvic examinations (paper 2) 
Our study on routine pelvic examinations is both a variation study and a direct measurement 
of overuse. The given premise for the latter approach is that routine pelvic examinations are 
unwarranted. We perceive routine pelvic examinations within special health care in Norway 
as unwarranted based on lack of evidence on beneficial outcomes,100 explicit 
recommendations against the practice,100-102 and the Norwegian health authorities’ warnings 
against screening outside of screening programs.70,71 However, as with blood pressure 
thresholds, there is some professional disagreement among different guideline panels. Based 
on moderate quality evidence, the American College of Physicians, the Canadian Task Force 
on Preventive Health Care, and the American Academy of Family Physicians strongly 
recommend against routine pelvic examination.100-102 The US Preventive Task Force and the 
American College of Obstetricians and Gynecologists conclude that there is insufficient 
evidence to either support or recommend against the practice.130,131  
In ICD-10, the Z01 codes are limited to “persons without complaint or reported 
diagnosis,” and the Z01.4 code is specified for “Gynaecological examinations 
(general/routine).”113 It is possible that women referred to specialized health care for 
evaluation of various symptoms receive a Z01.4 diagnosis if the examination is negative. This 
would represent coding error, as ICD-10 codes Z03 should be used for “[m]edical observation 
and evaluation for suspected diseases and conditions” in “persons who present some 
symptoms or evidence of an abnormal condition which requires study, but who, after 
examination and observation, show no need for further treatment or medical care.”113 
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Fee-for-service gynecologists receive personal reimbursement for reported codes of 
colposcopy or ultrasound. The same procedures reported by hospital physicians do not lead to 
extra payment neither to the physician personally nor to the hospital. Thus, fixed salary 
physicians are potentially less thorough in their reporting with a consequently underreporting 
of the use of colposcopy and ultrasound in hospitals. Nevertheless, the magnitude of the 
observed differences can hardly be explained by hospital underreporting.  
6.2.4 Diverticular disease (paper 3) 
ICD-10 codes for diverticular disease, K57, do not differentiate between diverticulosis, 
diverticular bleeding, or diverticulitis. Our study is therefore not able to differentiate across a 
spectrum of disease severity where also asymptomatic patients may have been diagnosed with 
diverticular disease. However, it seems hypothetical that patients were hospitalized without 
symptoms, especially as the great majority of admissions were acute.  
ICD-10 differentiate between diverticular disease with and without perforation. We 
wanted to examine if differences in code severity influenced regional utilization patterns. 
However, variation studies can only be applied to services of some extent; for rare conditions 
and seldom procedures observed regional variations is likely to be random and not 
systematic.123 The numbers of hospitalizations and outpatient appointments for diverticular 
disease with and without perforation were too small for further analysis. Similarly, it was not 
possible for us to analyze regional yearly rates or investigate surgery rates at the health 
enterprise level. 
Regional differences in code setting for diverticular disease and less specified 
conditions might be a source of error. It is possible that some patients with diverticular 
disease were coded as ICD-10 code R10, “Abdominal and pelvic pain.” We explored the 
distribution of R10 and chose to omit this code from the analyses as R10 was the discharge 
diagnosis in almost twice as many hospitalizations and over three times as many outpatient 
appointments as K57 and the age distribution of the two codes differed substantially. 
Moreover, we only had access to discharge diagnoses. Consequently, if the regional variation 
observed was due to regional differences in code accuracy this would seemingly reflect 
regional variation in diagnostic intensity including use of LGI endoscopy and CT 
examinations. The observed correspondence between LGI endoscopy for any indication and 
outpatient appointments for diverticular disease strengthens this interpretation. 
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6.3 Discussion of main findings 
In paper 1 we found that the practice of deferred CT KUB for patients with self-limiting 
episodes of suspected urolithiasis did not lead to surgical intervention in the great majority of 
asymptomatic patients. In paper 2 we found extensive use and regional variation of routine 
pelvic examinations. Fee-for-service gynecologists used colposcopy and ultrasound strikingly 
more frequent than fixed salary gynecologists. In paper 3 we demonstrated that 
hospitalization and outpatient rates for diverticular disease were about twice as high in high 
use regions compared to low use regions. Outpatient appointment rates for diverticular 
disease were strongly correlated to outpatient use of LGI endoscopy performed on any 
indication. 
6.3.1 CT for suspected urolithiasis (paper 1) 
In paper 1, we found the practice of routine deferred CT KUB to be low-value. Three 
asymptomatic patients (1.8%) received surgical treatment after a positive finding of 
urolithiasis on CT KUB, whereas only one treated patient had hydronephrosis, a scenario 
where treatment is clearly indicated.132 The great majority of patients referred to deferred CT 
KUB remained asymptomatic after the initial suspected stone episode.  
Wimpissinger et al. has reported some level of hydronephrosis in almost two thirds of 
asymptomatic ureteral stones. In this study, 1.1% of all patients (40 of 3711) diagnosed with 
ureteral stones were asymptomatic.133 In a screening trial, Boyce et al. found asymptomatic 
urolithiasis and hydronephrosis in 0.0008% of adults (4 of 5047).134 Unquestionably, 
asymptomatic urolithiasis exists and can cause both hydronephrosis and potential kidney 
damage.133-135 The question is how to balance the small risk of asymptomatic urolithiasis and 
kidney damage following an acute symptomatic suspected stone event versus the benefits and 
harms associated with CT diagnostics.  
We believe one case of a week-long symptomatic period followed by asymptomatic 
urolithiasis and hydronephrosis should not alone justify routinely referring all patients with 
self-limiting episodes of suspected urolithiasis for imaging diagnostics. Others might argue 
differently. The reliability of symptom assessment in prediction of obstruction is debated also 
for post-operative urolithiasis patients. The incidence of asymptomatic obstruction following 
treatment is exceedingly low, reported from 0 to 4%.97 The American Urological Association 
states that “Imaging all ureteroscopy patients to detect the rare case of silent obstruction is not 
cost-effective” and “This need-to-treat value is hardly justifiable from a strictly economic 
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viewpoint. Nonetheless, the Panel believes that the relatively low cost and lack of ionizing 
radiation associated with renal sonography justifies its use in routine follow-up of patients 
treated for ureteral stones.”97 The panel does not address harms of false positive findings or 
incidentalomas associated with imaging diagnostics. 
Traditionally, a confirmed diagnosis is perceived as beneficial. A quarter of 
asymptomatic patients got a confirmed diagnosis of urolithiasis after CT KUB. However, two 
thirds of CT diagnosed asymptomatic patients had kidney stones with median stone size 3 
mm. It is unlikely that such small kidney stones were causing the acute symptoms patients 
were experiencing at the time of referral.136 It is reasonable to believe that the referral 
symptoms of many patients had no connection to the finding on CT KUB. Hence, it is 
possible that a considerable proportion of the CT diagnosed cases represent incidental 
findings. 
Our positive yield was considerably lower than 66 to 70%, which was reported in the 
studies the European Association of Urology refer to in their support for CT diagnostics.137-140 
Those reports dealt with acute investigation and are therefore not directly comparable to our 
results. Furthermore, the referred studies are twenty years old. The positive yield today will 
likely be lower as the use of CT KUB has seemingly increased 20-fold from 1996 to 2011 
while a comparable increase in diagnosed urolithiasis has not been seen.141,142 Chen et al. 
reported a drop in diagnosed cases from 49% to 28% from one year to the other, presumably 
caused by more liberal use of CT diagnostics.143  
In the acute setting, CT KUBs ordered by an urologist or emergency room physician 
are significantly more likely to confirm a stone diagnosis than CTs ordered by any other 
doctor (67-73% vs. 39-43%, respectively).144,145 Comparing our results with the latter group, 
our results indicate that the suspicion of urolithiasis is less likely to be well-founded when the 
clinical presentation not necessitate acute investigation. Our lower diagnostic yield might to 
some degree also be explained by spontaneous passage before deferred CT diagnostics. 
However, time from referral to CT was not a significant predictor for a confirmed stone 
diagnosis. Women in our study had a lower positive yield than men, which is in accordance 
with previous studies.144-147 
In close to one out of ten CT KUBs we examined, the patient received either a false 
positive urolithiasis diagnosis or a diagnosis of a potential malignant process where further 
testing concluded with insignificant findings. All cases led to either additional CT scans, 
physician visits, or both.  In the benefit-to-harm balance of CT diagnostics for urolithiasis, 
these findings should be appraised.   
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The practice of deferred CT KUB for patients with self-limiting episodes of suspected 
urolithiasis is yet to be proven beneficial for patients with symptoms for less than a week, for 
younger patients, and for women in general. We recommend that the routine practice should 
be discontinued. Patients who remain pain free after an initial short episode should be 
informed about potential benefits and harms of CT diagnostics and participate in shared 
decision making on whether or not CT KUB should be performed.  
6.3.2 Routine pelvic examinations (paper 2) 
In our paper we demonstrated widespread use of routine pelvic examinations in Norway with 
extensive variation across hospital referral regions. Our study revealed extensive overuse of 
health care services and inappropriate and unnecessary screening procedures.  
The majority of women examined were between 25 and 69 years old. The age 
distribution in our study is in correspondence with the age group invited for cervical cancer 
screening in Norway.148 This finding suggests that a large proportion of women who received 
a routine pelvic examination, probably had the examination as an expanded part of cervical 
cancer screening.  
It is not surprising that women seek gynecologists for cervical screening. The 
Norwegian Consumer Council have reported that one out of ten regular general practitioners 
do not offer pelvic examinations at all.149 The Norwegian Cervical Cancer Screening 
Programme lists general practitioners and gynecologists as equal alternatives for performing 
the screening exam.148 Also for insertion of intrauterine contraception, there is an observed 
shift from primary to specialized health care.150 However, the World Health Organization 
stresses that “all aspects of health care performance can suffer” if health care systems fail to 
provide “the right care at the right time in the right place.”151 There is no medical need for 
gynecological expertise when performing cytology screening. Accordingly, “the right place” 
for cervical screening should be primary care. If women in our study were examined by 
gynecologists for cervical screening, our study demonstrates overuse of specialized health 
care services.  
The extensive use of colposcopy and ultrasound adds to this overuse. Whether or not 
women in our study received specialized health care for cervical screening or a routine 
examination outside the screening program, colposcopy and pelvic ultrasound are either way 
not indicated in asymptomatic women. The procedures are not a routine part of the 
Norwegian Cervical Cancer Screening Programme and should not be performed as a part of 
the screening program unless there is a visible lesion, or the cytology test result is abnormal.  
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The variation in routine pelvic examinations across regions was substantial. As all 
examined women were gynecologically healthy by definition, differences in morbidity should 
not explain the regional variation. With our data we cannot identify the causes for the 
observed variation. Possible explanations include regional differences in supply of both 
gynecologists and general practitioners and differences across regions in professional 
opinions regarding routine examinations. Either way, apart for cytology testing, there is no 
pelvic screening program in Norway. Both the substantial regional variation and any routine 
pelvic examination outside a screening program are per se unwarranted in regard to the 
Norwegian Patients’ Rights Act87 and in regard to the Norwegian health authorities’ concerns 
about opportunistic screening.70,71 We perceive the observed use of routine pelvic 
examinations as unwarranted overuse of health care services and an example of supply-
sensitive care.26 
The differences between fixed salary and fee-for-service gynecologists in use of 
colposcopy and ultrasound were striking. Patient preferences might hypothetically explain 
some of the variation observed both between provider types and across regions. However, it 
seems highly unlikely that women examined by fee-for-service gynecologists actively seek 
colposcopy while women examined at public hospitals opt out the procedure. Moreover, the 
procedures are not recommended screening examinations and do not fulfill the screening 
criteria set by the Norwegian Directorate of Health.70 Colposcopy and pelvic ultrasound are, 
to our knowledge, not a routine part of any public screening program anywhere in the world. 
Screening colposcopy and vaginal ultrasound should not be offered within publicly funded 
health care regardless of patient preferences.  
Fee-for-service is acknowledged as the main driver for the high medical expenditures 
in the USA. The National Commission on Physician Payment Reform recommends payers to 
“largely eliminate stand-alone fee-for-service payment to medical practices because of its 
inherent inefficiencies and problematic financial incentives.”152 The World Health 
Organization warns against fee-for-service as “over-servicing is the inevitable result.”153 For 
primary care, there is some evidence that fee-for-service results in more physician visits 
compared to capitation and salary payment, and in more specialist visits and both diagnostic 
and curative procedures compared to capitation.154 In gynecology, more elective services are 
performed under fee-for-service compared to capitation.155 However, evidence on practice 
differences between physicians with different payment models is limited and reviews on 
patient outcomes are missing.154,156  
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In studies examining differences between provider types, it is difficult to assess if the 
observed differences in provided care are caused by payment differences or other aspects, i.e. 
differences in population, morbidity etc. These potential biases should hardly affect our 
results as the women by definition were healthy and the examinations unwarranted for any 
healthy woman. We feel convinced that the observed differences in use of colposcopy and 
ultrasound are examples of fee-for-service led unnecessary health care services.  
The tariff code for “complete examination” is a potential co-driver to this overuse. In 
Norway, all publicly funded private specialists, not only gynecologists, are motivated to 
perform thorough examinations through the tariff code for “complete examination.” The code 
can be claimed when the physician has taken a precise history and a complete status preasens 
specific for the respective specialty. The necessity of such an examination is not questioned. 
As fee-for-service physicians already get extra reimbursement for every procedure they 
perform, the value of this additional “complete” code should be evaluated. In our study, we 
wonder if fee-for-service gynecologists might have been motivated to perform both 
colposcopy and ultrasound not only by the procedures themselves, but also to justify 
reimbursements claims for the well-paid “complete examination.” 
Contrary to popular belief, recommendations against screening pelvic examinations is 
not about depriving women of a well-documented beneficial health examination due to cost 
containment. The recommendations are based on lack of evidence on beneficial outcomes in 
addition to evidence on negative adverse effects. For the well-being of Norwegian women, we 
argue that Norwegian gynecologists should stop their practice of routine pelvic examinations 
in healthy women. 
This discontinuation of specialist practice should include cervical screening. Health 
authorities should take steps to transfer cervical screening within the Norwegian Cervical 
Cancer Screening Programme to primary care. Gynecologists, general practitioners, and 
health authorities alike should inform patients and the general public about the pitfalls of 
screening and why pelvic screening exams including additional procedures are unnecessary 
and unwarranted. Today, the Cancer Registry of Norway informs women that they can have 
their Pap test taken either by a general practitioner or by a gynecologist.148 We recommend 
that the Cancer Registry change this information and informs Norwegian women that there is 
no need for gynecological expertise when performing a Pap test.  
Pelvic examinations are intimate and may cause physical discomfort and emotionally 
distress.157,158 Due to the nature of the exam, some women might prefer to be examined by a 
female physician or any other physician than their regular general practitioner for cervical 
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screening. However, we believe that the organization of the screening program should be 
debated and settled on a national level to ensure equality in health services across the country. 
If special circumstances, i.e. history of abuse, warrants referral to specialized health care for 
cervical screening, the screening exam should be limited to Pap or human papillomavirus 
tests and visual inspection of the cervix.100  
6.3.3 Diverticular disease (paper 3) 
We demonstrated considerable regional variation in both hospital admission and outpatient 
appointment rates for diverticular disease. Regional outpatient appointment rates for 
diverticular disease were strongly correlated to the use of LGI endoscopy for any indication. 
The degree of regional variation and the correlation with diagnostic intensity of LGI 
endoscopy point to health care utilization that is influenced by regional differences in clinical 
practice independent from disease burden.  
The stable hospitalization and surgery rates over the study years indicate a relatively 
stable disease burden. This observation is contrasted by the large increase in outpatient 
appointment rates in the same period. The increase in outpatient appointment rates for 
diverticular disease closely follows the increase in rates of outpatient LGI endoscopy for any 
indication. Diverticulosis is a very frequent finding on LGI endoscopy for any indication, 
with 43% of examinations ending with a diverticulosis diagnosis.108 Hence, it is not surprising 
that diagnoses of diverticular disease follow the diagnostic intensity of LGI endoscopy. As 
outpatient appointments for diverticular disease were correlated to both time trends and 
regional rates of LGI endoscopy for any indication, the diagnostic intensity of LGI endoscopy 
seem to highly influence outpatient appointment trends for diverticular disease. In 2019 a 
national colorectal cancer screening program will be launched in Norway.159 Based on our 
results, we predict a high increase in diverticular disease diagnoses following colonoscopy 
screening implementation.  
Regional hospitalization and outpatient appointment rates were strongly correlated and 
might reflect increased morbidity in high rate regions. The correspondence might also reflect 
regional variation independent of disease burden where differences in clinical practice and 
professional views influence both hospitalizations and outpatient care in a similar way. As 
outpatient appointments also were strongly correlated to LGI endoscopy, it is possible that 
labeling patients with a diverticular disease diagnosis might affect hospitalization patterns.  
Surgery for diverticular disease has been used as a surrogate for disease severity.160 
The observed differences across regions in surgery rates might reflect real differences in 
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morbidity. However, the majority of surgery performed was elective. Evidence for optimal 
long-term follow-up and recurrence prevention for symptomatic diverticular disease is very 
limited.54,161 There are no routine indications for elective surgery after uncomplicated cases of 
diverticulitis, and guidelines lack criteria for when elective surgery should be 
recommended.112 An American study on acute diverticulitis showed that surgeon 
characteristics predicted surgical decisions independent of disease severity.162 In our study, 
the regions of South-Eastern Norway Health Authority had both the lowest rates of surgery 
and the lowest proportion of elective surgery. Hence, the low surgery rate might be explained 
not by low morbidity, but by a more defensive clinical practice regarding elective surgery.  
It is well known that the prevalence of diverticular disease varies across countries and 
continents. Due to the geographical differences, diverticulosis has been described as a disease 
of the Western world.107 Several factors including urbanization, low fiber intake, and obesity 
have been studied and are thought to play a role in the development of diverticulosis, though 
the pathogenesis is not fully understood.107,163,164 Variation studies within countries are 
limited. Neither dietary fiber nor body mass can explain the differences observed in admission 
rates across different American regions.163 Data on body mass, lifestyle, and diet is not 
collected on a population level in Norway, so unfortunately, we could not adjust for these 
perceived risk factors. Even though we were unable to identify the exact causes of the 
observed variation, we believe that the extent of variation across regions points to health care 
utilization that is associated with supply-sensitive care.26 Documented lack of clinical 
consensus internationally and lack of a national implemented guideline support our 
interpretation. Although there may be regional differences in disease burden, it seems unlikely 
that morbidity alone can explain an almost doubling of hospitalizations between low and high 
rate regions and an even bigger variation in outpatient appointments. We believe that regional 
variation in clinical care independent of disease burden is likely to explain at least some of the 
demonstrated regional variation in health care utilization for diverticular disease.  
6.4 Further studies  
In this thesis we have demonstrated uncertainties and shortcomings of very common 
practices. Different clinical settings will have different questions to raise. There is a shortage 
of Norwegian publications under the overall heading of overuse. We would encourage 
medical professionals and communities to consciously identify practices that should be 
further studied in regard of unwarranted use and variation. Properly designed studies testing 
both benefits and harms of established, but understudied practices, are warranted.  
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For suspected urolithiasis, further studies are needed to answer what is the best 
diagnostic approach for patients with varying demographic and symptom characteristics. The 
practice of routine deferred CT KUB should be tested in a clinical trial. For diverticular 
disease, further studies should identify the causes of observed variation and whether or not 
patient outcomes differs across regions. The demonstrated differences in provided care 
between provider types in paper 2 and 3 should be further investigated. 
6.5 Consequences for care   
This thesis has highlighted the need for guidelines not only to provide a gold standard of 
disease diagnostics and treatment, but also to describe which patients who are likely to benefit 
from the proposed procedures and at what risk. Guidelines on urolithiasis and diverticular 
disease should be updated according to exiting international guideline standards where 
potential harms of recommended procedures should be described and weighted against 
potential benefits, and where patients’ values are taken into account.165 
The regional variation seen in paper 2 is not directly comparable to the variation 
demonstrated in paper 3. For paper 2, given that all of the registered routine pelvic 
examinations were truly examinations of asymptomatic women, the right level of care is close 
to, if not zero. The practice should be discontinued. For paper 3, as for variation studies in 
general, we cannot use the variation figures alone to judge what the right level of care is. We 
cannot conclude on either overuse or underuse in any given hospital referral area. 
Nevertheless, the variation demonstrated in both studies should be critically appraised by 
national, regional, and local health providers. Reasons for the observed regional variation 
should be identified and addressed.  
Health authorities should identify remedies to level off unwarranted differences 
between provider types. Paper 2 adds to previous reports on the negative impact fee-for-
service has on health care performance. The continuation of fee-for-service payments in its 
present form should be scrutinized. However, until reform, Norwegian health authorities can 
use the reimbursement system in a likewise manner as the National Health Service England to 
achieve a reduction in unwarranted procedures. The National Health Service England has 
listed 17 inappropriate interventions they aim to reduce by cancelling reimbursements.166 We 
believe neither routine pelvic examinations nor cervical screening should be reimbursed in 
specialized health care unless special indication. In addition, the tariff code for “complete 
examination” for fee-for service physicians should be thoroughly reviewed for all specialties. 
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The path from evidence to clinical change and improved clinical outcomes is 
challenging and time consuming for medical research in general.167 As with obstacles in 
medical guideline implementation,44 decades of regional variation studies have had some, but 
limited impact on clinical care.168 In Norway, years of atlas publications have not levelled of 
differences.89 Whereas documentation of regional variation is a first step, clinical change and 
improved patient outcomes are unlikely to happen without further involvement of health 
authorities in collaboration with clinicians.168 In this regard, I am happy that both the Minister 
of Health and the Norwegian Medical Association pay attention to unwarranted variation in 
healthcare and engage in reducing overuse.16,169,170 In September 2018 the Norwegian 
Medical Association launched the Norwegian version of Choosing Wisely: “Gjøre kloke 
valg.” In Choosing Wisely, different medical societies identify practices within their own 
specialty that are unnecessary or low-value. With reference to relevant evidence, the societies 
publish recommendations on common practices to avoid or question. I hope Choosing Wisely 
and likewise initiatives will be incorporated into every day clinical care.   
There are many questions yet to be answered in regard of potential unnecessary health 
care services in the clinical settings presented. It is easy to state that further studies are 
needed. However, the much more demanding task of dealing with uncertainties and shortage 
of evidence cannot be escaped by health care providers. Acknowledging the uncertainties 
embedded in medical practice and the potential harms of overdiagnosis, overtreatment and 
unnecessary health care should be an ongoing exercise for all health professionals and health 
authorities. In Norway, many hospital departments have routines for monthly or weekly 
“complication meetings.” By discussing procedure complications, the aim is to learn from 
mistakes and improve clinical care. I argue that unnecessary tests and treatments should be 
discussed in likewise formal settings. Harms, risks, and shortcomings of procedures should be 
addressed in guidelines and communicated to patients. Patients should be encouraged to ask 
the questions raised by Choosing Wisely; “Why do I need to take this test/treatment? What 





In the papers included in is thesis, we have studied unwarranted regional variation and use of 
health care services for three clinical conditions. Our results confirm that the increasing 
international focus on too much medicine and variation is relevant also for Norwegian health 
care. Based on our results, we conclude that the practice of deferred CT KUB for patients 
with a self-limiting episode of suspected urolithiasis is a low-value health care service. 
Unwarranted pelvic examinations are widespread with substantial regional variation. Fee-for-
service reimbursements seem to skyrocket the use of colposcopy and increase the use of 
vaginal ultrasound in screening examinations. We found regional variation in both 
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Extent, regional variation and impact of
gynecologist payment models in routine
pelvic examinations: a nationwide cross-
sectional study
Ingvild Mathiesen Rosenlund1*, Linda Leivseth2, Ingard Nilsen3, Olav Helge Førde2,4 and Arthur Revhaug1,5
Abstract
Background: Based on moderate quality evidence, routine pelvic examination is strongly recommended against in
asymptomatic women. The aims of this study was to quantify the extent of routine pelvic examinations within specialized
health care in Norway, to assess if the use of these services differs across hospital referral regions and to assess if the use
of colposcopy and ultrasound differs with gynecologists’ payment models.
Methods: Nationwide cross-sectional study including all women aged 18 years and older in Norway in the years 2014–16
(2,038,747). Data was extracted from the Norwegian Patient Registry and Statistics Norway. The main outcome measures
were 1. The number of appointments per 1000 women with a primary diagnosis of “Encounter for gynecological
examination without complaint, suspected or reported diagnosis.” 2. The age-standardized number of these
appointments per 1000 women in the 21 different hospital referral regions of Norway. 3. The use of colposcopy and
ultrasound in routine pelvic examinations, provided by gynecologists with fixed salaries and gynecologists paid by a
fee-for-service model.
Results: Annually 22.2 out of every 1000 women in Norway had a routine pelvic examination, with variation across regions
from 6.6 to 43.9 per 1000. Gynecologists with fixed salaries performed colposcopy in 1.6% and ultrasound in 74.5% of
appointments. Corresponding numbers for fee-for-service gynecologists were 49.2% and 96.2%, respectively.
Conclusions: Routine pelvic examinations are widely performed in Norway. The variation across regions is extensive.
Our results strongly indicate that fee-for-service payments for gynecologists skyrocket the use of colposcopy and increase
the use of ultrasound in pelvic examinations of asymptomatic women.
Keywords: Routine pelvic examination, Unwarranted examination, Fee-for-service, Regional variation, Ultrasonography,
Colposcopy
Background
Based on moderate quality evidence, routine pelvic
examination is strongly recommended against in asymp-
tomatic women [1–3], as is screening colposcopy [4] and
routine screening for ovarian cancer in asymptomatic
women [5–7]. In the Prostate, Lung, Colorectal and
Ovarian Cancer Screening Randomized Controlled Trial,
including 78,000 women, bimanual examination of the
ovaries was discontinued as no ovarian cancer was
detected merely by palpation [8]. Use of screening CA
125 and transvaginal ultrasound does not reduce ovarian
cancer mortality [8, 9] and is advised against [5, 10].
High rates of colposcopy do not decrease cervical cancer
incidence or mortality [11]. False positive screening test
results are associated with harm. Women screened for
ovarian cancer have a 33% increased risk of oophorec-
tomy [8] and for every screening detected cancer ten
women undergo surgery following a false positive ultra-
sound examination [9]. Ultrasound of the pelvis should
not be performed unless clear indications are present
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[12]. Pelvic examination prior to provision of hormonal
contraceptives does not identify women who should
avoid these contraceptives and is not recommended as
routine practice [13].
The Norwegian public health system is well developed
with access for all inhabitants. All citizens have a legal
right to equal access to good quality health care [14]. All
citizens are entitled to a regular general practitioner
who, if necessary, refers the patient to specialized care.
Apart from abortions, women themselves cannot make
an appointment at a publicly reimbursed gynecologist
without a referral.
The municipalities of Norway are allocated into 21 dif-
ferent hospital referral regions. Each region has a defined
health enterprise responsible for providing specialized
health care for their inhabitants. The health enterprises
collaborate with private physicians to varying degrees. In
Norway all gynecologists at public hospitals are paid a
fixed salary, while a fee-for-service model pays private
gynecologists that collaborate with the health enterprises.
Methods
Aims
1. To quantify the extent of routine pelvic
examinations within specialized health care in
Norway.
2. To assess if the use of these services differs across
hospital referral regions.
3. To assess if the use of colposcopy and ultrasound
differs with gynecologists’ payment models.
Study design
Nationwide cross-sectional study on routine pelvic
examinations within specialized health care in Norway.
Setting
The Norwegian Patient Registry (NPR) contains health
reports on every appointment within publicly funded
specialized health care in Norway. Both public hospi-
tals and private gynecologists that collaborate with the
health enterprises report diagnoses of every patient
appointment to NPR. The appointments are linked to
the patients through the personal identification num-
ber of all inhabitants of Norway. Data from NPR is
used for central planning of specialized health care,
activity based financing, quality indicators, and health
care research. Through Centre for Clinical Documen-
tation and Evaluation (SKDE) we had access to reports
for 2014–16 in addition to annual population statistics
from Statistic Norway. One author (LL) had access to
indirect personally identifiable data from NPR. All
analyses and results are anonymous.
Participants
We included all Norwegian women aged 18 years and
older in Norway in the years 2014–16 (n = 2,038,747).
Variables and data sources
In this study private gynecologists who get public reim-
bursement are for simplicity called “fee-for-service gyne-
cologists.” The term “fixed salary gynecologists” is used
for gynecologists working in public hospitals, as the sal-
aries of these gynecologists are independent of quantity
of care. Data from privately out-of-pocket paid gynecolo-
gists’ practice is not included in the study as such data is
not recorded in Norway.
Both fixed salary and fee-for-service gynecologists
used the International Classification of Diseases version
10 (ICD-10) for reports to NPR. The Norwegian versions
for 2014–16 were in use during the study years. The
three versions are identical for the codes we have stud-
ied [15]. All gynecologists also reported the municipality
and city district code for the patients’ residency. We
used these codes to allocate appointments to the differ-
ent hospital referral regions.
We defined routine pelvic examination as a primary
diagnosis of ICD-10 Z01.4; “Encounter for gynecological
examination without complaint, suspected or reported
diagnosis.” Cervical screening was defined as a primary
diagnosis of the ICD-10 code Z12.4; “Encounter for
screening for malignant neoplasm of cervix.”
For hospital appointments colposcopy was defined by
the allocation of the code LXE00 (colposcopy) in the
2014–16 versions of The NOMESCO Classification of
Surgical Procedures (NCSP) [16]. Ultrasound was defined
by the allocation of any of the codes LXDE05 (transvaginal
ultrasound), SLXOBK or SLXOAK (transvaginal ultra-
sound of female pelvic organs) in the 2014–16 versions of
the Norwegian Classification of Medical Procedures
(NCMP) and the Norwegian Classification of Radiological
Procedures (NCRP) [16]. For fee-for-service gynecologists
colposcopy and ultrasound were defined either by the same
procedure codes or by the allocation of the codes 208 (col-
poscopy) and 211c (transvaginal ultrasound) in “Tariff for
publicly funded private physicians” versions 2014–16 [17].
In addition “complete examination” at a fee-for-service
gynecologist was defined by the allocation of the tariff code
4b1 (allowance for complete examination performed by a
specialist (after referral)).
Both publicly funded hospitals and fee-for-service gyne-
cologists that get public funding are obligated to report
surgical, medical, and radiological procedures according to
NCSP, NCMP, and NCRP to NPR. In addition, fee-for-
service gynecologists include tariff codes from “Tariff for
publicly funded private physicians” in the reports sent to
NPR. For each individual tariff code they report they get
extra reimbursement. It is known that some fee-for-service
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physicians underreport NCSP and NCMP codes. There-
fore we also included the more thoroughly reported tariff
codes to the definition of colposcopy and ultrasound for
fee-for-service gynecologists.
Statistical analysis
We obtained the age-standardized number of appoint-
ments for routine pelvic examination per 1000 women
in Norway, and for the 21 different hospital referral
regions. We also quantified the use of colposcopy and
ultrasound in appointments for routine pelvic examin-
ation for women examined by gynecologists with fixed
salaries and fee-for-service gynecologists, respectively.
Differences between provider types were compared with
Pearson’s chi-square test. For fee-for-service gynecolo-
gists the number of appointments with codes for “Allow-
ance for complete examination performed by a specialist
(after referral)” was also examined. All numbers reported
are the annual mean for 2014–16, unless otherwise
stated.
There were missing data for municipality code in 0.5%
(215) of appointments annually. As it is likely that
patients do not travel far for routine pelvic examina-
tions, we analyzed these appointments according to the
referral region where the examination took place.
In additional analyses, we quantified the extent of
cervical screening tests within specialized health care in
Norway, and we examined if differences across hospital
referral regions in routine pelvic examinations were
depended on differences in cervical screening tests. We
also examined if the use of colposcopy and ultrasound,
and variation across regions in pelvic examinations were
depended on registered secondary diagnosis.
We used SAS Enterprise Guide 7.1 [18] to analyze
the data.
Patient involvement
Patients were not formally involved in the planning or
conduction of the study. However, the subject under
investigation involves all Norwegian adult women
including the female authors of this paper.
Results
The estimated adult female population of Norway in the
years 2014–16 was 2,038,747. Nationally there were 22.2
pelvic examinations per 1000 women (Table 1). Of
women who received a pelvic examination during the
years of investigation, the majority (88.9%) had only one
exam. The number of appointments per patient was 1.04
annually and 1.14 during the 3 year period.
Women aged 25–69 years constituted 87.6% (39,589)
of appointments. Annually, 2.6% (38,065) of women aged
25–69 years had a routine pelvic examination, while
0.97% (2231) of younger women and 0.96% (3143) of
those aged 70 years or older were examined (Fig. 1).
Pelvic examinations per 1000 women ranged from 6.6
to 43.9 across hospital referral regions (Fig. 2). Fee-for-
service gynecologists performed two thirds (29,324) of
pelvic examinations with the mean age of women exam-
ined being 1.1 years higher than at fixed salary gynecolo-
gists (47.8 vs. 46.7 years). Colposcopy was used in 1.6%
(249) and ultrasound in 74.5% (11,810) of appointments
at fixed salary gynecologists, while fee-for-service gyne-
cologists used colposcopy in 49.2% (14,427) and ultra-
sound in 96.2% (28,216) of appointments (Fig. 3).
Differences in use of colposcopy (p < .001) and ultra-
sound (p < .001) between provider types were statistical
significant.
In addition 87.3% (29,324) of appointments in private
practice had a procedural code for “complete examin-
ation performed by a specialist.”
Additional analysis showed that there were 2013
appointments within publicly funded specialized health
care for cervical screening appointments annually. Cervical
screening constituted 4.3% of the combined number of
appointments for cervical screening and routine pelvic
examinations. The use of ultrasound was equivalent in
appointments for cervical screening and routine pelvic ex-
aminations (91.3 vs. 88.6%). Both fixed salary and fee-for-
service gynecologists used colposcopy more frequently in
appointments for cervical screening compared to routine
pelvic examinations. Fixed salary gynecologists used
colposcopy in 9.8% (13) of cervical screening appointments
(routine pelvic examination: 1.2%). The corresponding
number fee-for-service gynecologists was 69.8% (1310)
(routine pelvic examination: 49.2%). Fee-for-service gyne-
cologists performed 93.3% (1877) of cervical screening
examinations. Out of these 87.4% (1641) had a reimburse-
ment code for “complete examination performed by a spe-
cialist.” Adding cervical screening appointments to the
analysis of regional variation caused minor sequence
replacements for three regions while the national extent of
variation did not change (Additional file 1).
In 16.5% (7472) of appointments one or more secondary
diagnoses were registered. During the 3 year period there
were 856 different secondary diagnoses from almost all
Table 1 Appointments for routine pelvic examinations in Norway,
2014–16
Measures 2014 2015 2016 Annual mean
2014–16
Patients, n 44,731 41,941 43,644 43,439
Appointments, n 46,619 43,534 45,382 45,178
Appointments per
1000 women
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chapters in ICD-10. The variation in use of colposcopy
and ultrasound between appointments with and without
secondary diagnoses was minimal compared to the differ-
ences between fixed salary and fee-for-service gynecolo-
gists (Table 2).
Excluding appointments with secondary diagnoses in
the analysis of regional variation caused minimal
sequence replacements of five regions (Additional file 2).
Discussion
Principal findings
Routine pelvic examinations are widespread in Norway.
Annually, 22.2 per 1000 adult women received a pelvic
examination that is recommended against. The variation
across hospital referral regions was extensive and ranged
from 6.6 to 43.9 per 1000 women. Gynecologists with fixed
salaries performed colposcopy in 1.6% and ultrasound in
74.5% of appointments, while fee-for-service gynecologists
performed colposcopy in 49.2% and ultrasound in 96.2% of
appointments. Fee-for-service payments for gynecologists
seem to drive the utilization of colposcopy and ultrasound
in routine pelvic examinations.
Interpretation
This is the first study to document the widespread use
of unwarranted routine pelvic examinations in Norway.
The great majority of examinations were performed on
women aged 25–69 years. The Norwegian Cervical























Fig. 1 Number per 1000 women receiving routine pelvic examinations by age groups. Annual mean for the years 2014–16
Fig. 2 Age-standardized number of appointments for routine pelvic examination per 1000 women by hospital referral region and type of provider
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Cancer Screening Programme recommends and reminds
all women between the age of 25 and 69 years to have a
cytology test done every 3 years [19]. The correlation
between cervix screening age and the age distribution in
this study indicates that a large proportion of women
with a routine pelvic examination may have had the
extended examination as part of cervix screening. The
number of appointments for each woman was 1.14 dur-
ing the 3 years study period, which further strengthens
this interpretation.
The real extent of routine pelvic examination in special-
ized health care seems to be higher than our study reveals,
as the content of health care delivered in cervical screening
appointments is equivalent to what is demonstrated in
routine pelvic examinations. Pelvic examination, pelvic
ultrasound and colposcopy are not indicated in asymptom-
atic women and are not part of The Norwegian Cervical
Cancer Screening Programme, unless the result of the
cytology test shows cause for concern [19]. There are
separate ICD-10 codes for abnormal cervical cytological
findings [15]. If women in our study actually were referred
to specialized health care for routine testing within The
Norwegian Cervical Cancer Screening Programme, our re-
sults demonstrate overuse of specialist health care services
as cervical screening is supposed to be a primary care
undertaking. This reflects a recently observed shift from
primary to specialized health care for insertion of intra-
uterine contraception [20]. The finding of high numbers of
colposcopy, ultrasound, and “complete examinations” in
cervical screening appointments adds to this overuse.
Based on our findings, we argue that primary care physi-
cians should perform cervix screening.
Concomitant cervix screening cannot explain the
extensive regional variation observed. Neither can differ-
ences in morbidity across the regions, as the women
examined were by definition healthy. Geographical vari-
ation is shown to be associated with supply sensitive
care [21]. The extent of variation in the present study
points to examinations that are dependent on local
health care practice and supply.
While the American College of Physicians, the Canad-
ian Task Force on Preventive Health Care and the
American Academy of Family Physicians strongly rec-
ommend against routine pelvic screening examinations,
the debate is not settled. The US Preventive Services
Task Force Recommendation Statement concludes “that
the current evidence is insufficient to assess the balance
of benefits and harms of performing screening pelvic
examinations” [22]. The American Congress of Obstetri-
cians and Gynecologists reaffirmed in 2016 their Com-
mittee Opinion which purpose is “to explain the need
for annual assessments” albeit “at this time, this recom-
mendation is based on expert opinion” [23].
The academic ambiguity concerning routine pelvic
examinations might be reflected in our findings of exten-






































Fig. 3 Proportion (%) of appointments with colposcopy and ultrasound in routine pelvic examinations by comparison of fixed salary and
fee-for-service gynecologists
Table 2 Colposcopy and ultrasound in routine pelvic
examinations by comparison of payment model and whether or
not the appointment had a registered secondary diagnosis.
Annual mean for the years 2014–16
Fixed salary gynecologist Fee-for-service
gynecologist
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a referral, the regional variation might be explained by
regional differences in referral pattern. However our
study cannot answer if the observed variation is due to
regional differences in: supply (i.e. the number of gynecol-
ogists to refer to); professional belief in and tradition for
routine examinations; or the proportion of examinations
performed by primary care physicians and gynecologists,
respectively.
Either way, there is no pelvic screening program in
Norway. Both the extensive regional variation and the
extent of routine pelvic examinations per se are unwar-
ranted in regard to the Norwegian Patients’ Rights Act
[14] and in regard to the Norwegian Medical Associa-
tions concerns on opportunistic screening [24].
Health expenditures are increasing worldwide and
account for more than 12% of gross domestic product in
OECD countries [25]. Apart from Luxembourg, no coun-
try spends more on publicly financed health care per capita
than Norway [26]. It is recognized that fee-for-service
reimbursement is the most important driver of high med-
ical expenditures in the United States [27]. Fee-for-service
in primary care has been reported to be associated with
more visits, diagnostic tests and referrals compared to
salary payment, though evidence is limited [28]. Ransom et
al. have demonstrated that elective gynecological proce-
dures are performed more frequently under fee-for-service
than capitation payment [29]. The present study supports
these findings as fee-for-service gynecologists used colpos-
copy and ultrasound 31.2 and 1.3 times more often than
gynecologists with fixed salaries, respectively. Fee-for-
service gynecologists have an economic incentive to
extend the examination not only through the tariff for
colposcopy and ultrasound, but also through reimburse-
ment for “complete examination.” This code was used in
87.3% of fee-for service appointments.
Theoretically, patient preferences might explain some
of the differences between provider types and also the
regional differences. However there is no evidence that
patient preferences have much impact on regional vari-
ation [30]. It is highly unlikely that healthy women
referred to fixed salary physicians opt out colposcopy
while the majority of women examined by fee-for-
service gynecologists actively want this procedure. More-
over colposcopy and ultrasound are advised against in
the screening setting, and should not be an offer within
publicly funded healthcare regardless of preferences.
Our results strongly imply that fee-for-service payments
for gynecologists skyrocket the use of colposcopy and
drive the use of “complete examinations” and ultrasound
in pelvic examinations of asymptomatic women.
Recalibrating fee-for-service payments is recommended
as one measure to constrain unsustainable health care
expenditures [27]. Based on our findings, we argue that
reimbursements for routine pelvic examinations including
complete examination, colposcopy and ultrasound in
women not registered with any symptom, complain or
diagnosis should be discontinued. If gynecologists perform
cytology screening in healthy women, any extra reimburse-
ment should be removed.
Generalizability
To our knowledge, no other studies have quantified the
national extent of routine pelvic examinations within
publicly funded specialized health care. In Norway there
has never been a national guideline recommending
pelvic examination in asymptomatic women, nor a
screening program for ovarian cancer. “Well-woman
visits” [23] are not advocated by any Norwegian health
authorities and the majority of women are unfamiliar
with the practice. It is reasonable to believe that Norway
scores relatively low on the number of routine pelvic ex-
aminations compared to countries with traditions and
recommendation for annual assessments, and countries
with a higher degree of fee-for-service-reimbursements
for gynecologists.
This study only quantifies the use of pelvic examinations
within publicly funded specialized health care. Private
gynecologists with public funding constitute 43.5% of all
private gynecologists in Norway [31]. The remainders are
privately paid. The number of routine pelvic examinations
paid out-of-pocket is unknown, as is the number
performed by primary physicians. There is no reason to
believe that privately paid gynecologists perform routine
pelvic examinations any less than publicly funded gynecol-
ogists. On the contrary, privately paid gynecologists com-
monly advertise for routine pelvic examinations, hence, we
believe that our study substantially underestimates the total
amount of unwarranted pelvic examinations in Norway.
Strengths and limitations
The major strength of the study is the inclusion of all
Norwegian adult women and that the studied codes give
the basis for actual reimbursements paid to hospitals
and fee-for-service gynecologists. Registration and
reporting of appointments is compulsory and economic-
ally important for both hospitals and fee-for-service gy-
necologists. Correct reporting is focused on and stressed
in both settings.
There are several limitations inherent in the method-
ology of register studies. Code practice may vary across
regions. Underreporting of secondary diagnosis is expected
[32]. Fee-for-service gynecologists get reimbursement
according to the procedures they perform, while fixed sal-
ary gynecologists neither get compensated personally nor
get more reimbursements to the hospital by performing
colposcopy or ultrasound in routine pelvic examinations.
Hence, it is possible that fee-for-service gynecologists are
more thorough in their reporting, and that the actual use
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of colposcopy and ultrasound especially in hospitals is
underreported. Still, it is highly unlikely that this can
explain the huge differences observed.
Conclusions
Annually, 22.2 per 1000 adult women in Norway received
a publicly funded pelvic examination that is recommended
against. The variation across regions was extensive. Our
results strongly indicate that fee-for-service payments for
gynecologists skyrocket the use of colposcopy and
increase the use of ultrasound in routine pelvic examina-
tions. We argue that the reimbursement for these exami-
nations should be discontinued, not only as a measure to
constrain the unsustainable growth in health care expen-
ditures, but also for the wellbeing of healthy women.
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Erratum 
In the article “Extent, regional variation and impact of gynecologist payment models in 
routine pelvic examinations: a nationwide cross-sectional study” the definition of colposcopy 
at hospital appointments should correctly read:   
“For hospital appointments colposcopy was defined by the allocation of any of the codes 
XLE00 or LXE00 (colposcopy) in the 2014–16 versions of The NOMESCO Classification of 
Surgical Procedures (NCSP).”  
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ABSTRACT
Objective: To investigate the use of specialized health care services for diverticular disease in different
hospital referral regions in Norway.
Materials and methods: Nationwide cross-sectional study with data from the Norwegian Patient
Registry and Statistics Norway. All Norwegian inhabitants aged 40 years and older in the years
2012–16 (2,517,938) were included. We obtained the rates (n/100,000 population) for hospitalizations,
outpatient appointments, and surgery for diverticular disease for the population in each hospital refer-
ral region. We also quantified the use of lower gastrointestinal (LGI) endoscopy in hospitalizations and
outpatient appointments for diverticular disease and the use of LGI endoscopy performed on
any indication.
Results: There were 131 hospitalizations and 381 outpatient appointments for diverticular disease per
100,000 population annually. Hospitalization rates varied 1.9-fold across regions from 94 to 175.
Outpatient appointment rates varied 2.5-fold across regions from 258 to 655. Outpatient appointments
were strongly correlated to hospitalizations (rs¼0.75, p< .001) and outpatient LGI endoscopy for any
indication (rs¼0.67, p< .001). Hospitalization and surgery rates remained stable over the study period,
while outpatient appointment rates increased by 37%. Concurrently, rates of outpatient LGI endoscopy
performed on any indication increased by 35%.
Conclusion: There was considerable regional variation in both hospitalizations and outpatient appoint-
ments for diverticular disease. The extent of variation and the correlation with diagnostic intensity of
LGI endoscopy indicate that the regional variation in health care utilization for diverticular disease to a
large extent can be explained by regional differences in clinical practice rather than disease burden.
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Diverticular disease is common in Western countries. Two
thirds of people above the age of 80 are affected with diver-
ticulosis [1]. In an American study diverticulosis were found
in "30% of 50–59 years old, 50% of 60–69 years and 65% of
70–79 years old [2]. However, only 4% of patients with diver-
ticulosis will develop symptomatic disease during their life-
time [3]. Studies from North America and Europe have
reported increasing hospitalization rates for both diverticulitis
and diverticular disease for various time spans since 1988,
reaching a plateau in recent years [4–9]. The mortality has
remained relatively stable [4,10]. In the United States diver-
ticular disease is the most common discharge diagnosis in
hospital admissions for gastrointestinal disease and the 6th
most common physician diagnosis in outpatient visits [11].
The economic burden of diverticular disease on health care
services is increasing [10–12].
Diverticular disease is a condition with great variation in
severity, and care is often based on the individual physician’s
clinical discretion [9]. Traditionally, acute uncomplicated
diverticulitis has been treated with hospitalization, dietary
restrictions and antibiotics intravenously [13]. These
approaches are not supported by evidence. Several random-
ized controlled trials have shown no evidence of benefit of
antibiotic treatment for acute uncomplicated diverticulitis
[14]. Outpatient management without antibiotics is demon-
strated to be effective, safe and feasible [15]. Guidelines on
diverticular disease commonly lack reference to high quality
evidence for diagnostics, treatment, and follow-up and differ-
ent guidelines provide opposing recommendations [16,17].
Internationally there is more non-consensus than consensus
on management approaches with variation in care also
within regions [18].
In Norway there is no national guideline for diverticular
disease. However, the Norwegian Directorate of Health pub-
lishes guidelines on use of antibiotics in both hospitals and
primary care. The international non-consensus seems
reflected in these two separate national guidelines: For pri-
mary care, antibiotics and a liquid diet is recommended for
mild diverticulitis [19]. For hospitalized patients, however,
antibiotics are not recommended in uncomplicated cases
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and the guideline offers no recommendation on dietary
restrictions [20].
For various medical conditions with poor evidence for
optimal treatment and care, local practice and utilization of
health care services varies considerably over regions and
hospitals. Regions with higher utilization do not achieve bet-
ter health outcomes, patient satisfaction or lower mortality
as compared to regions with less utilization [21–23]. Lack of
guidelines increases the possibility for practice variation and
guidelines without a sound scientific basis do not contribute
to leveling of differences [21]. Within the United States there
is considerable variation in admission rates for diverticulitis
over different geographical regions with a 54% higher rate in
the Northeast compared to the West [8]. Such variation
within European countries has not been investigated.
Objective
To investigate if there are regional variation in hospitalization




Nationwide cross-sectional study on hospitalization and out-
patient appointment rates for diverticular disease of the
large intestine in different hospital referral regions.
Setting
Norwegian municipalities are distributed into 21 different
hospital referral regions, run by separate Hospital Trusts.
Within each referral region there are one or more public hos-
pitals and a varying number of private hospitals and special-
ists, practicing on the basis of reimbursement agreement
with the Hospital Trust. The Hospital Trusts are in turn run
by four regional health authorities [24]. By investigating dif-
ferences in health care utilization across the different regions,
we can find differences in provided care for the population
independent of where the treatment was given.
All providers of publicly funded specialized health care in
Norway are obliged to report diagnoses and procedures of
every patient appointment to the Norwegian Patient
Registry. Through Centre for Clinical Documentation and
Evaluation (SKDE) we have access to reports for 2012–16 in
addition to annual population statistics from Statistic
Norway. One author (LL) has access to indirect personally
identifiable data from the Norwegian Patient Registry. All
presented analyses and results are anonymous. The
Norwegian Data Inspectorate licensed the data registry at
SKDE (ref. 15/00271-2/CGN and 16/00289-2/CGN).
Participants
We included all Norwegian inhabitants aged 40 years and
older in the years 2012–16 (2,517,938).
Variables and data sources
Diagnoses were reported to the Norwegian Patient Registry
according to the International Classification of Diseases ver-
sion 10 (ICD-10). The annual Norwegian editions for 2012–16
were in use during the study years [25].
We defined diverticular disease of the colon as a primary
diagnosis of any of the ICD-10 codes K57.2–57.9: ‘Diverticular
disease of large intestine’ and ‘Diverticular disease of intes-
tine, part unspecified’. We excluded appointments with con-
current colon or rectal cancer (ICD-10 codes C18-C21) or
colitis (ICD-10 codes K50-52). Due to few hospitalizations and
outpatients appointments among younger age groups, we
included only patients 40 years old or older.
Hospitalizations were defined as hospital discharges with
length of stay #1 day and outpatient appointments were
defined as appointments with length of stay =0day. Patients
discharged as dead were classified as hospitalized regardless
of length of stay. For both hospitalizations and outpatient
appointments the degree of urgency was reported as acute
or elective. If patients were transferred between different
wards, each ward stay was coded separately as acute or
elective in the data from the Norwegian Patient Registry. We
defined hospitalizations as acute where the first ward stay
had a code for acute admission. Private physicians commonly
report degree of urgency incorrectly. Hence, outpatient
appointments at private physicians were defined as elective
as the responsibility to provide acute care with emergency
duty, emergency rooms and out-of-hours organisation is
delegated to public hospitals [26,27].
For outpatient appointments in hospitals lower gastro-
intestinal (LGI) endoscopy was defined by the allocation of a
procedure code for colonoscopy (UJF 32, JUF 32), colonos-
copy with biopsy (UJF 35, JUF 35), sigmoidoscopy (UJF 42,
JUF 42), sigmoidoscopy with biopsy (UJF 45, JUF 45) or
endoscopic polypectomy in colon (JFA 15) in the Norwegian
2012–16 versions of The NOMESCO Classification of Surgical
Procedures [28]. For outpatient appointments at private
physicians LGI endoscopy was defined either by the same
procedure codes or by the allocation of any of the codes for
colonoscopy (115a) or sigmoidoscopy (114a) in ‘Tariff for
publicly funded private physicians’, versions 2012–16 [29].
‘LGI endoscopy for any indication’ was defined as LGI endos-
copy use independent of allocated ICD-10 codes.
Surgery was defined by the allocation of a procedure
code for colonic resection (JFB 20-97), colectomy (JFH 00-96),
colostomy (JFF 20-31 and 96-7) or peritoneal drainage and
irrigation (JAK 00-04) in The NOMESCO Classification of
Surgical Procedures. We defined acute and elective surgery
as surgery performed in acute and elective admissions,
respectively. We only registered whether or not discharges
had surgery codes, not the extent of procedures within
one stay.
We defined ‘private physicians’ as either physicians work-
ing at private hospitals with public reimbursement, or physi-
cians with public reimbursement for their private practices,
so called fee-for-service physicians. Fee-for-service physicians
get extra reimbursement for every procedure they perform,
as do the private hospitals. Details on how physicians at
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private hospitals are paid are not official. Physicians at public
hospitals are paid a fixed salary independent of quantity of
care. In Norway there is no recorded data on privately out-
of-pocket paid practices, hence, such data is not included in
this study.
Data on municipality code was missing in 0.5% (15) of
hospitalizations and 0.3% (31) of outpatient appointments.
We analyzed these admissions and appointments according
to the referral region where the patient received care.
Statistical analysis
We obtained the rates (n/100,000 population) for hospitaliza-
tions and outpatient appointments for diverticular disease
for the population of Norway and the 21 different hospital
referral regions. We also quantified the use of LGI endoscopy
in hospitalizations and outpatient appointments for diverticu-
lar disease. Due to small numbers, we analyzed surgery by
the four Regional Health Authority regions. For hospitaliza-
tions, we calculated length of stay. To estimate the correl-
ation between outpatient appointments and hospitalizations
for diverticular disease we used Spearman’s correlation
coefficient.
In additional analyses we quantified LGI endoscopy for
any indication. We obtained the rates of hospitalizations and
outpatient appointments with a procedure code for LGI
endoscopy. To estimate correlation between regional rates of
outpatient appointments for diverticular disease and out-
patient LGI endoscopy for any indication and we used
Spearman’s correlation coefficient.
All reported numbers are the annual mean for 2012–16,
unless otherwise stated. All regional rates were standardized
by age and sex with January 1 2015 as the standard popula-
tion. We used SAS Enterprise Guide 7.1 (SAS Institute Inc.,
Cary, NY, USA) to perform all statistical analyses [30].
Results
Hospitalizations
In 2012–16, there were annually 3295 hospitalizations for
diverticular disease. Hospitalization rates were stable over
the study period (Table 1). More women than men were
admitted and admitted women were older than men
(Table 1 and Figure 1). Hospitalization rates across regions
varied 1.9-fold from 94 to 175 per 100,000 population
(Figure 2). Most patients (85%) had only one hospitalization
for diverticular disease during the 5-year period. The median
length of stay across regions varied from two to three days.
The majority (84%) of hospitalizations were acute admissions.
Surgery
In 13% of hospitalizations patients underwent surgery
(Table 1). National surgery rates for diverticular disease were
stable during the study years. Mean surgery rates for diver-
ticular disease in the study period varied 1.3-fold across
regions from 15 to 19. Elective surgery accounted for 53% of
the total amount (Table 2).
Outpatient appointments
In the study period, there were annually 9614 outpatient
appointments for diverticular disease. Rates for outpatient
appointments increased by 37% (Table 3). Differences
between women and men are shown in Table 3 and Figure
3. Outpatient appointments rates across regions varied 2.5-
fold from 258 to 655 per 100,000 population (Figure 4). Most
outpatient appointments (94%) were elective. The correlation
between outpatient appointments and hospitalizations across
regions was strong (rs=0.75, p< .001). Private physicians
accounted for 17% of all outpatient appointments, and fee-
for-service physicians accounted for 86% of these.
LGI endoscopy
In 15% of hospitalizations and 76% of outpatient appoint-
ments for diverticular disease LGI endoscopy was performed
(Table 1 and 3). Physicians at public hospitals performed LGI
endoscopy in 72% of outpatient appointments for diverticu-
lar disease, a percentage that was stable during the study
years (72–71%). In the same period private physicians
increased their use of this procedure from 94 to 99% of
appointments. Rates for outpatient appointments for diver-
ticular disease with LGI endoscopy increased by 39%. In
absolute numbers, outpatient LGI endoscopy for diverticular
disease increased by 33% at public hospitals and by 121% at
private physicians.
Table 1. Hospitalizations for diverticular disease for patients 40 years and older.
Year 2012 2013 2014 2015 2016
Hospitalizations, n 3212 3217 3253 3268 3524
Hospitalizations per 100,000a 131 130 129 128 136
Women, n (%)b 2084 (65) 2062 (64) 2107 (65) 2056 (63) 2250 (64)
Men, n (%)b 1128 (35) 1155 (36) 1146 (35) 1212 (37) 1274 (36)
Age, y, mean (w/m) 68 (70/64) 67 (69/65) 68(69/65) 67 (69/64) 67 (69/65)
Acute hospitalizations, n (%)b 2646 (82) 2715 (84) 2791 (86) 2753 (84) 2975 (84)
Elective hospitalizations, n (%)b 566 (18) 502 (16) 462 (14) 515 (16) 549 (16)
Surgery, n (%)b 438 (14) 396 (12) 379 (12) 412 (13) 440 (12)
Surgery per 100,000a 18 16 15 16 17
LGI endoscopy, n (%)b 493 (15) 477 (15) 476 (15) 484 (15) 546 (15)
LGI endoscopy per 100,000a 20 19 19 19 21
aPopulation by January 1 the following year as denominator.
bProportion of annual number of hospitalizations.
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In the same time period the rate of LGI endoscopy
for any indication increased by 31% with a 6% increase in
hospitalizations and a 35% increase in outpatient
appointments (Table 4). Outpatient LGI endoscopy for any
indication was strongly correlated to outpatient
appointments for diverticular disease across regions
(rs=0.67, p< .001).
Figure 2. Age- and sex-standardized rate of hospitalizations for diverticular disease by hospital referral region.
Table 2. Surgery for diverticular disease for patients aged 40 years or older
by Regional Health Authority region. Annual mean 2012–16.
Surgery, n
Surgery per
100,000 populationa Acute, n (%)
Northern 48 19 21 (44)
Central 67 19 31 (46)
Western 89 18 40 (45)
Southern and Eastern 209 15 101 (48)
aAge- and sex-standardized.
Figure 1. Hospitalizations as proportion of population by sex and age.
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Discussion
There was substantial variation in both hospitalizations and
outpatient appointments for diverticular disease across hos-
pital referral regions in Norway. Outpatient appointments
were strongly correlated to outpatient LGI endoscopy for any
indication in the general population. It is probable that the
regional differences observed in outpatient appointments
reflect regional differences in LGI endoscopy and not differ-
ences in diverticular disease morbidity alone.
The stable hospitalization and surgery rates point towards
a relatively stable disease burden, however contrasted by the
37% increase in outpatient appointment rates. In the same
time period rates of outpatient LGI endoscopy for any indica-
tion increased by 35%. Diverticulosis is the most common
finding on LGI endoscopy. In a large US study examining
more than half a million colonoscopies performed on any
indication including screening, diverticulosis was diagnosed
in 43% of cases [2]. The observed correspondence between
time trends of increased outpatient care for diverticular dis-
ease and increased use of LGI endoscopy for any indication
supports the interpretation that diagnostic intensity of LGI
endoscopy for any indication can explain trends in out-
patient appointments for diverticular disease. In Norway, a
national colorectal cancer screening program is planned to
be implemented from 2019 [31]. Health authorities and clini-
cians should be aware that diagnoses of diverticular disease
are likely to increase concurrently with increased use of
colonoscopy.
The strong correlation between hospitalization and out-
patient appointment rates might reflect a higher disease bur-
den in high rate regions. On the other hand, knowing the
strong correlation between LGI endoscopy for any indication
and outpatient appointments for diverticular disease, there
are other plausible explanations. Labeling patients with a
diverticular disease diagnosis after LGI endoscopy could pos-
sibly influence hospitalization patterns.
Variation in surgery rates may reflect real differences in
morbidity, although documentation on such differences in
Norway is nonexistent. The regions of Southern and Eastern
Norway Health Authority, with the lowest rates of surgery,
Table 3. Outpatient appointments for diverticular disease for patients 40 years and older.
Year 2012 2013 2014 2015 2016
Appointments, n 8057 8742 9465 10,163 11,642
Appointments per 100,000a 329 352 375 398 450
Women, n (%)b 4900 (61) 5334 (61) 5699 (60) 6024 (59) 6944 (60)
Men, n (%)b 3157 (39) 3408 (39) 3766 (40) 4139 (41) 4698 (40)
Age, y, mean (f/m) 67 (68/66) 67 (68/66) 67 (68/66) 68 (68/66) 68 (68/66)
Acute appointments, n (%)b 488 (6) 514 (6) 526 (6) 620 (6) 711 (6)
Elective appointments, n (%)b 7569 (94) 8228 (94) 8939 (94) 9543 (94) 10,931 (94)
LGI endoscopy, n (%)b 6022 (75) 6573 (75) 7275 (77) 7807 (77) 8864 (76)
LGI endoscopy per 100,000a 246 265 289 306 343
aPopulation by January 1st the following year as denominator.
bProportion of annual number of hospitalizations.
Figure 3. Outpatient appointments as proportion of population by sex and age.
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also had the lowest proportion of elective surgery. While evi-
dence for optimal treatment and care for the acute phase of
symptomatic diverticular disease is scarce, evidence for the
best approach for long-term follow-up and prevention of
recurrence is almost non-existent [16,32]. Surgery following
acute uncomplicated cases of diverticulitis should not be
performed routinely, and guidelines lack criteria for when
such surgery should be performed [17]. Hence, the regional
variation observed in surgery rates might rather reflect prac-
tice differences. Jafferji et al. have shown that surgical deci-
sions for diverticulitis are predicted by surgeon
characteristics independent of patient factors [33].
Geographical differences in the prevalence of diverticular
disease are well-known [1]. Western civilization, low fiber diet
and overweight have been associated with diverticulosis in
epidemiological studies and are frequently used to explain
geographical variations [1,8]. In Norway we have little data
on diet and body mass on an adult population level, so
unfortunately, we could not adjust for these variables in our
analyses. Neither overweight nor low fiber diet can explain
the geographical variation in hospitalizations for diverticulitis
within the United States [8]. The lack of high quality evi-
dence and guidelines regarding treatment and care, and the
extent of regional variation, suggest that health care
utilization for diverticular disease might be associated with
supply-sensitive care [21]. Although there may be regional
differences in risk factors and morbidity, it is unlikely that
this explains all observed variation. We believe that the dem-
onstrated regional variation in hospitalization and outpatient
rates at least in part are explained by local practices that are
independent of morbidity.
The sex difference in our study is in accordance with
other European and North American findings where more
men than women are hospitalized with diverticulitis in the
lower age groups and the opposite for older age groups
[4–9]. Causes to the observed sex differences is yet to be
demonstrated.
Important differential diagnoses to diverticular disease is
symptom diagnoses of abdominal pain. The diagnoses
reported in this study are the discharge diagnoses. Any dif-
ference in code accuracy would presumably mean differen-
ces in diagnostic intensity, i.e., the use of CT colonography,
CT abdomen and LGI endoscopy. As there is no national
guideline on diverticular disease, it is difficult to assess how
diverticular disease is dealt with both in primary and special-
ized care. In the manual for primary care out-of-hours ser-
vice, the manual recommends to ‘Consult the local guideline’
when advising on hospitalization for diverticulitis [34]. For
Figure 4. Age- and sex-standardized rate of outpatient appointments for diverticular disease by hospital referral region and type of provider.
Table 4. The number and rates of LGI endoscopy for any indication for patients aged 40 years or older by year and type of care.
Year 2012 2013 2014 2015 2016
Hospitalizations with LGI endoscopy, n 8176 8437 8899 9037 9194
Hospitalizations with LGI endoscopy per 100,000a 334 340 353 354 356
Outpatient appointments with LGI endoscopy, n 50,919 56,704 61,632 66,690 72,474
Outpatient appointments with LGI endoscopy per 100,000a 2081 2283 2445 2611 2804
aPopulation by January 1st the following year as denominator.
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patients handled ambulatory, the manual states ‘The GP
assesses need for further investigation (CT colonography)’,
not giving any further assistance on how to assess that
need. A national guideline on diagnostics, treatment and fol-
low-up for diverticular disease seems warranted and might
level off some of the regional variation observed in
this study.
By 2016 private physicians used LGI endoscopy in 99% of
outpatient appointments for diverticular disease compared
to 71% for physicians with fixed salaries. Fee-for-service reim-
bursements are demonstrated to be associated with high
rates of unnecessary procedures [35]. Our findings indicate
that the threshold for performing LGI endoscopy is lower for
physicians who benefit economically than for fixed sal-
ary physicians.
Strengths and limitations
A major strength of our study is that we included all patients
with a primary diagnosis of diverticular disease within pub-
licly funded specialized health care. With data from the
Norwegian Patient Registry and through the unique personal
identification number of every Norwegian citizen, we could
follow individuals over time. The limitations of our study are
inherent to patient registry analyses. We have only data on
discharge diagnosis. We could not validate the ICD-10 codes
reported. Unfortunately, ICD-10 codes do not allow for differ-
entiating between diverticulosis, diverticular bleeding or
diverticulitis. Appointments labeled with a diverticular dis-
ease diagnosis might have included also asymptomatic cases.
However, it is highly unlikely that patients were hospitalized
for asymptomatic diverticulosis; especially as more than five
out of six hospitalizations were acute admissions. Variation in
health care utilization across regions may represent both dif-
ferences in morbidity and code practice. Additionally, our
study evaluated only rates of hospitalizations and outpatient
appointments within specialized health care and did not
include cases of diverticular disease managed in a primary
care setting.
Conclusions
There was substantial regional variation in both hospitaliza-
tions and outpatient appointments for diverticular disease.
The extent of variation and the correlation with diagnostic
intensity of LGI endoscopy strongly indicate that regional
health care utilization for diverticular disease can partially be
explained by regional differences in clinical practice rather
than disease burden. Such unwarranted variation in clinical
practice should be addressed by the health authorities.
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